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Chapter 1 
General introduction and outline of the thesis 
In part submitted for publication 
Cervical cancer 
Cervical cancer is a major cause of death in women and the second most frequent cancer in 
women throughout the world, accounting for 15% of all malignancies in women (1) On the 
basis of descriptive biologic studies in the late 1960s Richart assumed that before cervical 
cancer arises the cervical mucosa must go through several non-invasive intraepithelial 
stages, which he called cervical intraepithelial neoplasia (CIN, 2-4) According to the WHO 
histologic classification of tumors of the uterine cervix, CIN is subdivided m CIN1 (mild 
dysplasia), CIN2 (moderate dysplasia) and CIN3 (severe dysplasia and carcinoma in situ). 
CIN1 corresponds to low-grade squamous intraepithelial lesions (LSIL) and CIN2 and 3 to 
high-grade squamous intraepithelial lesions (HSIL) in the Bethesda System for cytological 
classification (5,6) Squamous epithelial abnormalities less than CIN1 are called atypical 
squamous cells of undetermined significance (ASCUS, 6) To classify CIN, pathologists 
usually rely on histomorphological criteria, such as nuclear atypia, loss of maturation, 
absence of polarity and the presence of mitotic figures (7-9). Especially the frequency and 
the presence of atypical mitoses and the localisation of mitoses within the dysplastic cervical 
epithelium are used for the histopathological grading of CIN lesions (10) If mitoses and 
nuclear atypia are restricted to the basal third of the epithelium, the lesion is classified as 
CIN1. CIN2 and CIN3 are characterized by the presence of mitotic activity and nuclear atypia 
within the basal two thirds and whole thickness of the epithelium, respectively (11) 
The assumption that non-invasive CIN precedes invasive cervical cancer forms the basis of 
cytological national population screening programs Hereby, detection and treatment of 
intraepithelial lesions prevent progression to invasive carcinoma In most of the developed 
countries, women are educated about the risk factors and encouraged to participate in 
cytological screening programs set up by national governments A rapid decline in the 
incidence of cervical cancer and the mortality from this disease (from approx 35 per 100.000 
to 6 per 100.000) can be particularly attributed to the implementation of such screening 
10 
programs over the past 30-50 years (12-17) 
In the last decades, several large-scale long-term follow-up studies of women with CIN have 
shown that the risk for cervical cancer is relatively high for CIN3 CIN1 and CIN2 on the 
contrary have lower risks of progression In a Swedish series of 555 women with CIN1 who 
were surveyed for several years, only 16% of cases showed progression towards CIN3, 
whereas 62% regressed and 22% remained unchanged (18) Thus most women who were 
treated for an abnormal cytological Papanicolaou cervical smear (Pap smear) would never 
have developed cancer if left untreated (14) This situation is further worsened as minor 
epithelial cell changes such as ASCUS are treated more aggressively Many therapeutic 
modalities (cervical comsations, cryocoagulations, diathermic loop excisions, uterus 
resections, etc ) and the more intensive follow-up of women with ASCUS will have 
unfavorable health effects and will make cervical cancer screening much less cost-effective 
(16) 
Cyto- and/or histological examination of cervical intraepithelial abnormalities cannot 
distinguish regressive from progressive lesions Therefore, new diagnostic tests need to be 
developed to detect potentially progressive cervical lesions 
In the past decade there is growing evidence that human papillomaviruses (HPVs) play a 
pivotal role in the development of cervical cancer HPV gene products are able to influence 
different regulatory mechanisms of cell growth The increasing knowledge of the biology of 
cervical cancer provides the rationale and targets for development of ancillary diagnostic 
tests Histo- and cytochemical techniques on cervical specimens such as immunohisto-
chemistry, in situ hybridization (ISH), and comparative genomic hybridization (CGH) have 
become applicable in routine setting and research With these new techniques we are able to 
study the role of different phenotypic and genotypic markers in relation to the presence of 
HPV in cervical cells Additional biological markers can be used to detect progressive pre-
cancerous cervical lesions that need a more aggressive therapy as compared to persistent 
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and regressive lesions. 
Human papillomavirus 
HPV detection 
In the late 1970s epidemiological studies suggested that transfer of a sexually transmitted 
factor could explain the occurrence of cervical cancer in women (19-21). It appeared that 
high-risk factors for the development of cervical cancer and its pre-neoplastic stages (CIN) 
were low age at the onset of sexual activity, cigarette smoking, and having had multiple 
sexual partners (22-24). In 1977 Zur Hausen pointed out the possible etiological role of HPV 
in cervical cancer (25). Two decades before, Koss introduced the term "koilocytotlc atypia" 
for abnormal squamous epithelial cells from patients with CIN or cervical cancer (26). 
Koilocytotic cells exhibit vacuolization of the cytoplasm with condensation of the chromatin 
and slight atypia of the nuclei (Figure 1). High resolution imaging by electron microscopy 
clearly demonstrated viral particles in koilocytotic cells of CIN lesions (27-30). After the 
introduction of modern molecular techniques such as Southern blot hybridization and 
polymerase chain reaction (PCR), many epidemiological and clinicopathological studies 
demonstrated that HPV is associated with the development of CIN and cervical cancer (31-
36). 
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Figure 1. Koilocytotic cells. Cervical smear of a CIN1 lesion, showing cells with vacuolization 
of the cytoplasm and slight atypia of the nuclei (A; Pap, x500). Histological section of a CIN2 
lesion with vacuolated cells, exhibiting slight to moderate atypia of the nuclei (B; H&E, x250). 
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To date, more than 90 different types of HPV have been characterized (37) Two large 
groups of HPVs can be distinguished based on the site of infection cutaneous and genital 
(mucosal/cemcal) Most cutaneous HPV types (HPVs 1 2, 3, 4, 10 28 29 and 38) lead to 
benign lesions of the skin, like verruca plantaris, verruca vulgaris and verruca plana The 
group of genital HPVs is further divided by behavior of the involved cervical lesion Non-
oncogenic cervical HPV types (HPVs 6, 11, 40, 42, 43, and 44) are predominantly present in 
condyloma acuminatum, ASCUS, and CIN1 lesions Oncogenic types (HPVs 16, 18, 31, 33, 
35, 45, 51, 52, 56, and 58) are demonstrated in cervical cancer and also in CIN2 and CIN3 
lesions (38-40) Using sensitive general primers as My 11/09 and GP5+/6+ in the PCR, it 
appeared that nearly all cervical cancers are HPV DNA positive (41-43) To identify an 
individual HPV type, elaborate type-specific hybridization tests or type-specific PCR tests are 
necessary With the Line Probe Assay-Polymerase Cham Paction (Lipa-PCR) it is possible to 
detect 16 different HPV types in one sensitive and simple test (44) HPV DNA amplification 
was performed using a short PCR fragment (SPF-PCR) SPF-PCR uses 5'-end biotmylated 
primers and produces 65-bp fragments of the HPV L1 open reading frame The biotmylated 
PCR products were reverse-hybridized to a membrane strip containing 16 HPV specific 
oligonucleotide sequences (44) In a follow-up study of 152 women with an abnormal Pap 
smear, Melchers et al found with the LiPA-PCR that the presence of high-risk HPV types 
increased with the severity of the cervical lesion HPV was shown to be present m 51% of 
ASCUS, 78% of LSIL (CIN1), 86% of CIN2 and 88% of CIN3 The ratio of high-risk to low-
risk HPV types was 2 9, 18,5 and 28 m ASCUS, LSIL (CINI), and HSIL (CIN2 and 3), 
respectively (44) The results of the latter study and many other studies clearly disclose that 
infection with high-risk HPVs is involved m the progression of low to high-grade CIN and 
invasive carcinomas 
Organisation of the HPV genome 
Papillomaviruses belong to the DNA tumor virus family of the Papovavmdae, also including 
Simian virus 40 and polyoma virus The papillomaviruses consist of a circular double-
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stranded DNA genome approximately 8000 base pairs in length and enveloped by an 
icosahedral protein capsule of 45-55 nm in diameter (45) The HPV genome consists of three 
reading frames an 'early region' a 'late region, and a non-coding or upstream regulatory 
region (URR) (46) The early and late regions have several open reading frames (ORF's) 
resulting in translation of functional proteins The early region ORF's (E1, E2, E4, E5, E6, 
and E7) come to expression early in the viral life cycle E1 encodes proteins that maintain the 
viral genome The E2 gene products are involved in transcriptional regulation and control the 
E6 and E7 genes (47) The E4 gene encodes a protein that finally breaks off the cytoplasmic 
keratin networks, resulting in koilocytotic cells in the upper cell layers of the epithelium The 
function of the E5 gene is not fully understood in human cervical carcinogenesis E6 and E7 
encode multifunctional proteins that control proliferation and transformation The late region 
ORF's (L1 and L2) encode the capsule proteins of the virus and this expression is tightly 
bound with the host cell differentiation into mature keratinocytes in the upper cell layers of 
the epithelium (29) 
HPV infection and integration 
The enormous amount of molecular data about HPV-mediated carcinogenesis has emerged 
from in vitro studies of cervical carcinoma cell lines Infection with HPV is an early event in 
the multi-step process of cervical carcinogenesis In benign cervical lesions and low-grade 
CIN lesions the HPV genomes are maintained in an episomal state (free in the nucleus) At 
one point in the process of progression of CIN (probably m CIN3), HPV integrates into the 
host genome The process of integration in the human genome disrupts the E2 region and 
function of the virus E2 protein normally suppresses the function of E6/E7, therefore 
disruption will result in (enhanced) expression of these genes (47-49) Further research has 
demonstrated that high-risk E6 and E7 oncoproteins interfere with two pathways of the host 
cell that are critical in tightly regulating cell division the retinoblastoma protein (pRb) pathway 
and the p53 pathway The pRb pathway regulates passage through the cell cycle and the 
p53 pathway induces growth arrest (for DNA repair) or apoptosis (programmed cell death) 
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upon DNA damage (50). The interactions of E6 and E7 with both pathways are shown in 
Figure 2. 
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Figure 2 Interactions of E6 and E7 oncoproteins on the cell cycle. 
•pRbE2F 
E6 / p53; 
Oncogenic stimuli such as c-myc and ras activate p19(ARF). p19(ARF) prevents degradation 
of p53 by blocking of MDM2 for ubiquination of p53 (not shown in Figure 2) (50) In turn, p53 
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activates transcription of p21(Cip1), ρ27(Κιρ1), and p57(Kip2), all three potent inhibitors of 
cyclm-dependent kinases (CDK1, CDK2, and CDK4/6) The CDKs bind to cyclms facilitating 
rapid progression through the several checkpoints of the cell cycle, at early d (cyclin D,), at 
late G, (cyclin E), throughout S and G2 (cyclin A), and for entry into mitosis at Q-M boundary 
(cyclin B) (51) Cell cycle arrest or blockade initiated by p53, through for instance p21 gives 
the normal cell the opportunity for DNA repair at several checkpoints. Once arrested, the 
normal cell with errors in its DNA can be driven into programmed cell death (apoptosis) by 
means of the Bax/Bcl2 mechanism (52,53) On account of this action, p53 is called "guardian 
of the genome" Targeting of p53 by E6 proteins of high-risk viruses like HPV16 will lead to 
rapid degradation of p53. This effect disrupts the suppressing properties of p53 and makes 
blocking of the cell cycle (arrest for DNA repair) impossible (see Figure 2) Thus HPV E6 
impairs the ability to block the cell cycle upon DNA synthesis errors (54-56) 
In addition, E6 also induces telomerase activity preventing telomere shortening of the 
chromosomes After numerous cell cycle passages, the normal human cell will go into 
apoptosis when the length of the linear chromosome telomeres is reduced to a critical point. 
Increased telomerase activity will maintain the telomere lengths above a critical point and this 
will postpone the process of apoptosis (57). This mode of interaction of E6 is p53 
independent 
E7 / pRb: 
CDK4 and 6 regulate pRb by phosphorylation. Besides, p16(INK4a) can interfere with the 
binding of cyclin D1 to the CDK4/6 kinases, and preventing d / S progression (see Figure 2). 
As the host transcription factor E2F alone transactivates many genes important for mitosis, 
hypophosphorylated pRb <pRbE2F-complex) will repress E2F dependent genes, and 
blocking G^S progression. E7 protein of HPV 16 can effectively bind to pRbE2F resulting in 
release of the active host transcription factor E2F, upon which the cyclin-dependent kinases 
start the cell cycle (58). E7 protein also binds and inactivates CDK inhibitors (p21, p27, and 
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p16(INK4a) This mechanism also stimulates cell proliferation (see Figure 2) Inactivation of 
molecules involved in the pRb pathway by E7 in combination with telomere elongation (E6) 
is able to immortalize the epithelial cell (59) 
In Figure 3 the effects of the E6 and E7 oncoproteins on the cell cycle are summarized In 
short Absence of cell arrest and absence of apoptosis (E6), continuing of the life cycle by 
maintaining telomere lengths (E6), and hyperprohferation (E7) together are considered to be 
prerequisites for the cell to become immortalized or to obtain unrestrained growth Ultimately, 
after a critical number of genetic abnormalities, the host cell may achieve a fully malignant 
phenotype 
HPVE6 HPVE7 
p53 inactivation <i E6 > telomerase activation 
Ψ 
apoptosis inhibition 
Ψ 
Ψ 
maintaining 
telomerase lengths 
V 
continuing 
life cycle genetic instability 
Figure 3 Summarized effects of E6 and E7 on the cell cycle 
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Histopathology and HPV infection 
It would be quite satisfying if we could understand the role of HPVs in respect to the gradual 
morphological changes of low towards high-grade CIN lesions Recently, Stoler described an 
HPV-mediated carcinogenesis model of the pre-neoplastic CIN stages based on 
histopathology (49) To explain the low frequency of HSIL in comparison with LSIL and 
ASCUS, Stoler hypothesized that in high-risk HPV infected lesions a rare event must occur 
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This might be disruption or mutation of the HPV E2 gene, giving high E6/E7 expression High 
E6/E7 levels will lead to progression to a proliferative phenotype, and result in HSIL This 
explanation is however not in agreement with some observations that disruption of the E2 
gene occurs not until the virus is integrated in the host genome, an event that is assumed to 
occur in invasive cervical cancer and in some CIN3 lesions (60,61). Another explanation 
might be that the molecular activities of E6/E7 proteins of high and low-risk HPV are different 
(62). 
Up till now detailed studies about the in situ presence of high and low-risk HPV in LSIL on 
the one side and in HSIL on the other hand are lacking Therefore, more research and 
preferably in situ studies are needed to demonstrate the presence of HPV and with that the 
precise role of low and high-risk viruses in the generation of cervical lesions 
Hyperproliferation in CIN and Cervical Cancer 
In classifying CIN, pathologists use histomorphological criteria (nuclear atypia, absence of 
maturation, and frequency of mitoses) of which the number of mitoses, the localization of 
those and atypical mitoses (three group metaphases) are most helpful. Normal cervical 
epithelium shows normal mitotic figures in the basal layer of the epithelium, whereas 
increasing CIN exhibits a progressive increase of mitotic activity with atypical mitoses in the 
higher epithelial cell layers (8-10). It is likely that CIN is characterized by a progressive 
dysfunction of proliferate activity of cervical epithelial cells. In the early 1990s this hypothesis 
led to the exploration of new immunohistochemical antibodies to classify CIN in an objective 
way 
The monoclonal antibody PC10, directed against the proliferating cell nuclear antigen 
(PCNA), was used in semi-quantitative studies of routinely processed archival paraffin-
embedded CIN lesions (63,64) The application of PCNA related antibodies like PC10 in 
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grading of CIN was not unambiguous, because the biochemical properties of PCNA harbour 
complexities (65). PCNA expression, although tightly associated to the sides of DNA 
replication, can also be triggered by several growth factors and it has a rather long half-life 
time This implies that PCNA positive cells have already left the cell cycle (65,66) There are 
also important technical problems with the practical application of PC10 because the type of 
fixation or prolonged fixation can strongly influence PC10 reactivity (65,67) 
Another proliferation-associated monoclonal antibody, called MIB1, offers better prospects 
MIB1 recognizes an epitope on the Ki-67 antigen that is not influenced by routine formalin 
fixation. Ki-67 antigen is a non-histone protein with a short half-life time that is expressed 
during d , S, and G2M phases, but not in Go (resting phase) (68-70) Both, the short half-life 
of MIB1 and the fact that staining is not influenced by high dilutions make this antibody a 
more robust marker of cell proliferation than PC10 (71). A number of studies have reported 
the usefulness of MIB1 to analyze reactive and dysplastic changes of cervical epithelium (72-
75) A drawback of most of these studies is that a rather subjective semi-quantitative scoring 
method was used to evaluate the MIB1 positivity or labelling index (LI is percentage of MIBI 
positive cells) of abnormal cervical epithelium Therefore, we developed application software 
for an automatic image analysis system to quantify the LI and to measure the relative 
distance of Ki-67 expressing cells to the basement membrane of the cervical epithelium (see 
chapter two) 
There is strong molecular evidence that E6/E7 expression is necessary to drive proliferation 
in CIN and cervical cancer. High-risk HPV types, which were found in low and high-grade 
CIN lesions, showed significantly higher densities of MIB1 than low-risk HPV types that were 
exclusively found in low-grade CIN lesions (76). Others found that the MIB1 expression did 
not differ significantly in HPV-positive and negative CIN1 and 2 lesions However, the highest 
proliferation was demonstrated in the group of CIN3, the vast majority of which were 
HPV16/18 positive (77). These findings confirmed that infection with high-risk HPVs is 
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involved in the induction of hyperprohferation 
Approximately 10% of patients with LSIL or borderline lesions as ASCUS harbour high-grade 
lesions of the cervix. Therefore, many women with cytological detected low-grade lesions will 
be treated by conservative surgical procedures (78) Most of these patients (more than 90%) 
will never develop cervical cancer if left untreated Many studies established that MIB1 is a 
robust marker to classify cervical abnormalities in tissue biopsies and therefore, it was 
obvious that the applicability of this antibody should also be investigated in cytological 
specimens (see chapters three and four) Recently it was demonstrated that positive MIB1 
staining of cervical smears was a good predictor of high-grade CIN (79) 
Moreover, in daily practice other cytodiagnostic problems occur in which MIB1 staining could 
be of particular help. Atrophic cervical epithelium of older women is occasionally difficult to 
distinguish from high-grade-CIN in smears because it is composed of cells lacking 
differentiation. Pap smears of post-menopausal women may contain cell groups that cannot 
be classified as either atrophy or high-grade CIN The Pap smears will be repeated after a 
short course of oral or local estrogen therapy (see chapter four). Estrogens will induce 
maturation of atrophic epithelium, whereas abnormal epithelial cells of CIN will not change 
(80,81). Recently, the possible utility of MIB1 in distinguishing dysplasia from atrophy was 
evaluated in cervical biopsies It was found that atrophic cervical epithelium hardly expressed 
any MIB1-positivity, whereas high-grade CIN displayed extensive MIB1-positivity (82). We 
explored the possibilities of MIB1- (re-) staining of both cervical biopsies and Pap smears in 
the setting of atrophy versus high-grade CIN For that purpose an image analysis system 
was used to evaluate the proliferation-associated characteristics of atrophic epithelium (see 
chapter three) In addition, a MIB1-based decision tree was introduced and tested to triage 
postmenopausal women with "atypical" atrophic Pap smears (see chapter three and four). 
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Genetic instability in CIN and Cervical Cancer 
The full malignant phenotype will be reached after accumulation of genetic errors 
Chromosome instability is characterized by polyploidization of the whole genome loss or 
gam of chromosomes (aneusomy) chromosome regions or specific genes Since the late 
1960s, Atkm and co-workers have been at the forefront of cytogenetic analysis of solid 
tumors and cervical cancer in particular (83 84) Although no single cytogenetic abnormality 
has been consistently associated with cervical cancer, nonrandom involvement in structural 
changes of a number of chromosomes, particularly chromosomes 1, 3, 5, 11, and 17 has 
been shown (84) Structural rearrangements and aberrations, such as deletions and 
translocations isochromosomes and inversions have been described for chromosome 1 
(83,85,86) Chromosomal aberrations also have been reported for chromosomes 6, 13 16, 
18 and 22 (83,86-89) Trisomy and polysomy were described for all chromosomes (83,86) 
Cytogenetic studies by classical Giemsa-trypsm banding is hampered by complex banding 
patterns or inadequate metaphase preparations Recently, karyotype analysis for the 
identification of chromosomal rearrangements has been improved with the advent of 24-color 
fluorescence-ISH (FISH) analysis in a single experiment (90) It is difficult to make 
metaphase preparations from fresh material of pre-mvasive cervical tissues Most of the 
known cytogenetic data come from solid cervical tumors at advanced stages With the help 
of techniques such as DNA image cytometry, CGH, detection of loss of heterozygosity, and 
ISH with centromere-specific probes further characterization of the chromosomal changes of 
pre-mvasive stages is within reach All these rather new techniques have in common that 
metaphase preparations are not required for analysis 
Image cytometry (ICM) 
DNA cytometry is the quantitative measurement of the total nuclear DNA of individual cells 
DNA ploidy analysis can be performed by flow cytometric and image cytometric techniques 
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For both techniques nuclei are isolated from fresh or paraffin embedded tissues through 
disruption and enzymatic disaggregation In ICM, the nuclear suspension is cytocentrifuged 
onto glass slides and then stained with a Feulgen staining method The specifically stained 
DNA of the nuclei is quantified and compared to normal diploid cells, expressed as the DNA 
index, which is 1 0 for a diploid cell population ICM DNA ploidy patterns can be visualized by 
histograms displaying the amount of DNA present in stemlmes. According to the Convention 
on nomenclature for DNA cytometry, histograms may be assessed as DNA-diploid, DNA-
polyploid and DNA-aneuploid (91) In an ICM study of 468 cases Atkm demonstrated that 
cervical carcinomas in older patients tended to be near-triploid and tetra-ploid (92) ICM of 
cell suspensions or smears is the most straightforward method to detect DNA content in pre-
invasive stages A retrospective ICM study of cervical smears showed that progression of 
CIN1 or 2, to CIN3 (carcinoma in situ) was characterized by an increase in hypertetraploid 
DNA values (93) These earliest ICM findings in pre-mvasive cervical lesions are in 
accordance with the fact thai polyploidy is detected in low-grade lesions and aneuploidy in 
high-grade lesions and m progressive CIN lesions (94-98) 
Comparative genomic hybridization (CGH). 
CGH is a molecular technique that can m principle reveal all regions of amplification in a 
single experiment, together with any regions of allele loss or aneuploidy in DNA isolated from 
tissue The DNAs (test and reference) are differentially labelled (e g. in green and red) and 
subsequently hybridized to normal human metaphase chromosome spreads Differential 
fluorescent signals represent gains and losses of the test DNA relative to the reference DNA 
With the aid of image-processing software, ratios of the signals can be quantitated along the 
length of each homolog and changes in the ratio of green/red intensities reflect regions of 
amplification or of allele loss in the tumor (99,100). The combination of CGH with 
microdissection allows for genomic analysis of specific, small cell populations in for instance 
pre-mvasive lesions (CIN, 101) Heselmeyer reported gam of chromosome 3q (3q24-3q28) in 
one of thirteen CIN3 lesions (8%) and in nine of ten HPV16 positive cervical carcinomas 
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(90%) indicative for a sole genetic event marking the transition from CIN3 to invasive 
carcinoma (100) Losses of chromosomes or chromosomal subregions were also observed 
on chromosomes 3p, 4q and X in the group of cervical carcinomas (100) Kirchhoff confirmed 
these findings (102) The most consistent chromosomal gam was mapped to chromosome 
arm 3q in 35% of pre-mvasive cases and in 72% of cervical carcinomas These results are in 
accordance with a recent study of Matthews who found a gam of chromosome 3q the most 
common chromosomal aberration detected by CGH of cervical carcinomas (103) The latter 
study found a gam of 3q also in cervical adenocarcinomas whereas loss of 3p was 
exclusively present in the group of squamous cell carcinomas 
Detection of loss of heterozygosity (LOH) 
LOH also called allelic imbalance", is a key pointer to the existence of tumor suppressor 
(TS) genes By screening paired blood and tumor samples with markers across the genome, 
candidate locations for TS genes can be discovered Restriction endonucleases cut genomic 
DNA at specific recognition sequences The resulting DNA fragments vary in size and can be 
separated on a gel/membrane with electrophoresis and subsequently detected with a 
labelled probe specific for the genes under study (Southern blot technique) Normal DNA will 
show two bands with the Southern blot technique one paternal and one maternal allele 
locus In general, individual normal DNA will show two bands and it is considered 
heterozygous (informative) for the gene under study When tumor DNA is studied with 
specific locus probes and only one band is seen, the information at that specific locus is lost 
This loss of information is called LOH Initially, Southern hybridization with probes that detect 
restriction fragment length polymorphisms (RFLPs) was used to detect LOH Nowadays, 
PCR-RFLP (digestion of PCR-amplified DNA with allele-specific restriction enzymes) is used, 
as it is more sensitive than Southern-blot techniques and it can genotype DNA isolated from 
routinely processed formalin fixed tissue (104) In cervical carcinomas loss of specific 
chromosomal regions is reported for chromosome arms 3p, 4p, 5, 6, 11q and 17p (105) 
Most of the studied losses on chromosome regions contain TS genes There are few LOH 
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studies of CIN and losses were reported for 3p and 11q (106,107) These investigations are 
in accordance with a recent LOH study on 10 cases of CIN3 with simultaneously cervical 
cancer of which most were oncogenic HPV positive (105) As the CIN lesions were adjacent 
to the invasive tumors, it is likely that they were really progressive. In these progressive CIN 
lesions LOH, was already observed for several chromosome arms, particular 3p, 6p and 11q 
(in 5, 7, and 6 cases, respectively), indicating rather early events in cervical carcinogenesis. 
Especially in the cervical carcinomas LOH was seen for 6q, 17p and X, suggestive for late 
events. Interestingly, loss on 6p was located at 6p21/6p23, which harbor the HLA gene 
complex (105) As HLA molecules are necessary for the immunological fight against HPV 
infection, this finding may indicate that progressive CIN lesions escape the immune 
response. 
ISH with centromere-specific probes 
Tumor DNA analysis on Southern blots gives no information at the single-cell level To a 
lesser extent the same holds true when CGH analysis is performed At the moment the 
pathologist is confronted with final CGH results, the morphological information is lost In 
contrast to LOH and CGH, ISH is the obvious method for a direct detection of specific nucleic 
acid sequences in which simultaneously morphological analysis can be performed. Since 
chromosomes are generally organized into distinct domains in interphase nuclei, ISH can be 
applied to detect chromosome aberrations in non-mitotic cells Therefore, this technique is 
often called "interphase cytogenetics" (108) In particular for cell populations of limited size, 
as is mostly the case in pre-invasive lesions, interphase cytogenetics is of great importance, 
because it has the advantage to directly combine the morphological information to 
chromosomal abnormalities ISH DNA probes can be subdivided into three groups: 1) Probes 
for repeated DNA sequences specific for only one chromosome type. Centramene regions of 
human chromosomes carry chromosome-specific DNA sequences that are repeated behind 
each other several hundreds to several thousands times. ISH with centromere-associated 
DNA probes is especially used for chromome counting (numerical analysis), since their target 
24 
sequences are detected as dot-like signals This type of numerical chromosome counting is 
used in this thesis (see chapter five and seven) 2) Whole chromosome probes, which detect 
whole DNA sequences along the chromosome of interest These chromosome painting' 
probes are applied to analyze structural aberrations in metaphase preparations especially 
when different labelled probes are simultaneously used 3) Probes for specific loci of single 
genesthat range in size from 15 to more than 500 kb (109,110) 
With regard to the advantages of ISH with centromere-associated probes, it is remarkable 
that up till now there are only few studies using this method of analysing genetic instability in 
pre-mvasive cervical lesions Fluoresence-ISH with a centromere probe for chromosome 1 
on cervical smears, showed increased occurrence of polysomy with increasing CIN grade 
5 7% in normal cases, 14 4% in CIN1 30 8% in CIN2, and 69 6% in CIN3 (111) 
Objectives of this thesis 
The observations that high-risk HPVs inactivate pRb and degrade p53 have resulted in a 
fairly straightforward model on cervical carcinogenesis that gives openings for further 
climcopathological investigations Inactivation of pRb and p53 lead to hyperprohferation and 
genetic instability, respectively We used MIB1 for evaluation of proliferative activity in 
cervical lesions, as it is a robust and reliable antibody to detect the proliferation-associated 
Ki-67 antigen To explore genetic instability, we analyzed numerical chromosomal aber-
rations, using DNA-ISH with a panel of eight centromere-associated chromosome probes As 
a result, the centromere probe for chromosome 1 was selected to study the topological 
relation between numerical chromosomal aberrations and infection with high-risk HPV 
In Chapter 1 the two aspects of cervical carcinogenesis 1) cell proliferation, and 2) genetic 
instability reflected by numerical chromosomal aberrations in both CIN and cervical cancer 
are reviewed in relation to the presence or absence of HPV or certain HPV types 
Chapter 2 reports the application of an image analysis system to investigate proliferation-
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associated parameters that can be used to classify CIN lesions 
Chapter 3 is directed at the distinction of cervical atrophy from high-grade CIN in 
postmenopausal women by using proliferation-associated parameters In addition, a MIB1-
based decision tree is proposed to reduce diagnostic follow-up procedures 
Chapter 4 reports the investigation of a proliferation-associated parameter in MIBI-restained 
Pap smears of postmenopausal women with atypical atrophy or high-grade CIN These 
women underwent a diagnostic estrogen course and proliferation is assessed in MIBI-
restained Pap smears before and after estrogen therapy. Finally, the earlier proposed 
decision tree is tested to triage postmenopausal women with cervical atrophy and "atypia" 
Chapter 5 describes the investigation of numerical chromosomal aberrations in progressive 
and persistent CIN lesions and cervical cancer For this purpose ISH with a panel of eight 
centromere-specific DNA probes is used 
Chapter 6 shows the advantages of signal amplification with the catalyzed reporter 
deposition (CARD-ISH) procedure above the traditional ISH method in detecting HPV 
Chapter 7 describes the in situ presence of aneusomy for chromosome 1, simultaneously 
with oncogene HPVs using the CARD-ISH procedure and PCR 
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Chapter 2 
MIB1, a promising marker for the classification of 
cervical intraepithelial neoplasia 
Johan Bulten, Jeroen A W.M. van der Laak, Johanna H Gemmink, Martin M.M Pahlplatz, 
Peter CM de Wilde, Antonius G J. M Hanselaar 
Institute of Pathology, University Hospital Nijmegen, The Netherlands 
Journal of Pathology 1996, 178: 268-273 
Summary 
Formalin-fixed and paraffin-embedded tissue specimens of normal and dysplastic cervical 
epithelia (5 CINI, 7 CIN2 and 5 CIN3 and 5 normal) were assessed by an immunoperoxidase 
technique, using the monoclonal antibody MIBI, recognizing a formalin-fixation-resistant 
epitope on the cell proliferation associated Ki-67 antigen An image analysis system (VIDAS'US, 
Kontron, FRG) was used to measure four parameters associated with proliferative activity the 
KÌ67 labelling index (LI), the number of Κι-67-positive nuclei per unit length of basement 
membrane, and the maximum value and 90th percentile of the relative distances of Ki-67 
positive nuclei from the basement membrane All these four proliferation-related parameters 
were highly correlated with the grade of dysplastic change in the epithelium (0.90<r<0 97, 
p<0.0001). The best correlation was found for the 90th percentile of the relative distance and 
with this parameter all CIN lesions could be correctly classified The means and standard 
deviations of the Ki-67 Lis in normal epithelium, CIN1, CIN2 and CIN3 lesions were 0.07 ± 
0 03, 0 16 ± 0 03, 0 25 ± 0 06 and 0.39 ± 0 06, respectively. These findings support the theory 
that CIN involves a progressive dysfunction of the proliferative activity of cervical epithelial 
cells Image analysis of MIB1 is a promising alternative method for the objective, reproducible 
and reliable classification of dysplastic changes in cervical epithelium 
Key words: CIN, proliferation, Ki-67, MIB1, monoclonal antibody, immunohistochemistry, 
quantitative analysis. 
Introduction 
To classify cervical intraepithelial neoplasia (CIN), pathologists usely rely on histomorpholo-
gical criteria, such as absence of maturation, nuclear polymorphism, loss of polarity and the 
frequency of mitoses (1,2,3). The number of mitoses, the presence of atypical mitotic figures 
and the localisation of mitoses are particularly used for the histopathological grading of lesions 
(4,5) In normal cervical epithelium mitotic figures are rarely encountered, when present, they 
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are confined to the basal layer and are never abnormal In CIN lesions, the mitotic figures 
occur more frequently, are found in suprabasal layers of the epithelium, and often have an 
atypical appearance (5) These observations suggest that CIN involves a progressive 
dysfunction of proliferative activity of cervical epithelial cells, whereby proliferating cells are 
found at progressively higher levels of the epithelium with increasing CIN grades (6) 
Recent semi-quantitative immunohistochemical studies on formalin-fixed and paraffin-
embedded archival matenal, using the monoclonal antibody PC10 which recognizes the 
proliferating cell nuclear antigen (PCNA), have given further support for this hypothesis (6,7) A 
significant positive correlation (r=0 75, p<0001) was found between the CIN grade and a semi-
quantitative PCNA grade, based on the highest level at which positive cells were seen in the 
epithelium (6). The PCNA grade, however, is not suitable for a reliable classification of CIN 
lesions and normal cervical epithelium, since only 45% of CIN lesions were correctly classified 
by this means. The disagreement between the histopathological and PCNA grades might be 
partly explained by the arbitrary grading system chosen to quantify the proliferative activity 
and/or by the monoclonal antibody selected to visualize the proliferating cells The limitations of 
antibodies that recognize PCNA have been descnbed (8). In a more recent paper, the same 
authors have demonstrated that the monoclonal antibody MIB1 is superior to the PC10 
monoclonal antibody (9). MIB1 is a novel monoclonal antibody that recognizes a formalin 
fixation-resistant epitope on the cell proliferation-associated Ki-67 antigen (10,11) Ki-67 
antigen is a short-lived non-histone protein, which is expressed during the G1, S, and G2IM 
phase of the cell cycle and not in the GO phase (resting phase) (12,13). 
In this study, the MIB1 monoclonal antibody was used to immunohistochemically visualize the 
proliferating cells within CIN lesions. Application software was developed for an automatic 
image analysis system which enables a quantitative analysis of the proliferating fraction (Ki-67 
labelling index) and the localization of the proliferating cells within the cervical epithelium The 
aim of this study was to investigate whether this quantitative analysis of MIB1 -positive cells 
could be of value for an objective classification of CIN lesions 
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Materials and methods 
Patients 
Formalin-fixed and paraffin-embedded cervical biopsies of 22 patients were used, including 5 
CINI, 7 CIN2, and 5 CIN3 lesions, and 5 cervical biopsies without histopathologic abnormali­
ties Standard 5 μπι thick hematoxylin and eosin-stamed sections were used for the grading of 
the lesions. The cases were selected from the archives of the Department of Pathology, 
University Hospital Nijmegen. The cervical lesions were graded independently by two 
pathologists There was agreement concerning the CIN grade between them in 19 cases 
(86%). The diagnoses of the pathologists were different in 3 CIN lesions (14%), but in none of 
these cases was the difference in the grade of the CIN lesions greater than one The ultimate 
grade of CIN was obtained by consensus with a third pathologist. One case was ultimately 
classified as CIN2 (initially graded as CIN1 and CIN2, respectively), one case as CIN2 (initially 
graded as CIN2 and CIN3, respectively) and the third case as CIN3 (initially graded as CIN2 
and CIN3, respectively). 
Immunohistochemistry 
Three-micrometer thick paraffin sections were mounted onto polylysme-coated slides and dned 
overnight at 37°C Paraffin sections were dewaxed in xylene and rehydrated in a series of 
graded alcohols Rehydrated slides were placed in a citrate buffer (10 mM, pH 6 0) and heated 
in a household microwave oven at 90"C for 20 mm. After microwave preprocessing, the 
sections were allowed to cool down to room temperature. Subsequently, the slides were briefly 
washed with phosphate-buffered saline (PBS, pH 7.4) and an indirect immunoperoxidase 
technique was used to visualize the Ki-67 antigen, utilizing the following incubation steps The 
sections were incubated with the mouse monoclonal antibody MIB1 (Immunotech S.A , 
France) 1:40 in PBS with 2% normal calf serum overnight at 4Ό and subsequently incubated 
with a rabbit-anti-mouse peroxidase (Dakopatts, Denmark) 1100 in PBS for 60 minutes at 
room temperature The peroxidase-labelled complex was developed with diammobenzidine 
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(DAB, Vector Laboratories) for 4 mm at room temperature and intensified with 5% CuS04 for 5 
mm at room temperature. All incubation steps were followed by three washes in PBS of 5 min 
Subsequently the slides were slightly counterstamed with Mayer's haematoxylm, dehydrated in 
ethanol and xylene, and finally mounted 
Image Analysis 
The slides were analysed using a CCD RGB camera (Sony CA-325P) mounted on top of a 
light microscope (Axioskop, Zeiss) and attached to a VIDASP'US image analysis system 
(Kontron Ine , Germany) A x20 objective with a numerical apperture of 0 5 was used for image 
acquisition, resulting in pixels with dimension of 0 39X0 41 μπι In each tissue specimen, 5 to 7 
fields representative for the CIN lesion were selected and digitized for analysis. 
For each digitized RGB image, the following procedure was performed. First, curves were 
drawn interactively by the operator to define the Ipcation of the basement membrane and the 
boundary of the most superficial epithelial layer Next, the red component of the RGB image 
was used to define all (MIB1-negative and MIBI-positive) nuclei a background image was 
constructed by mean filtering (window size of 25X25 pixels) of this image Then the difference 
between the red image and the background image was interactively thresholded. On the 
resulting binary image, a dilation, a filling of holes, and an erosion were successively 
performed to improve the segmentation result All resulting objects were individually labelled as 
nuclei 
To define MIBI-positive nuclei, the blue component of the RGB image was interactively 
thresholded, as the contrast for the brownish/red positive nuclei was the highest in this image. 
Then objects with an area less than 10 pixels were removed and every nucleus, defined in the 
red image, that had any overlap with an object in the resulting image was defined as a MIBI-
positive nucleus. The segmentation results were displayed as an overlay on the original RGB 
image, which could, be used by the operator to make corrections interactively for misclassified 
nuclei or to reprocess the image. 
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The relative distances of each positive nucleus from the basement membrane and surface 
were determined as follows. For each positive nucleus, the distance to the basal and to the 
superficial curve, respectively, were determined from Euclidean distance maps of images 
containing these curves (14). From these distances, the relative distance of a positive nucleus 
from the basement membrane was calculated; a value of zero indicates that the nucleus was 
located at the basement membrane and a value of one means that the nucleus was located in 
the most superficial layer The number of MIB1-positive nuclei, the total number of nuclei, and 
the length of the basal layer of the epithelium were also measured in each field. From these 
quantities several proliferation-associated parameters can be derived and four parameters 
were selected the fraction of MIB1-positive nuclei (Ki-67 labelling index), the number of MIB1-
positive nuclei per unit length of basement membrane, the maximum value of the relative 
distance, and the 90th percentile of the relative distances of MIB1-positive nuclei from the 
basement membrane The latter parameter was chosen because the 90th percentile ε more 
stable than the maximum value of the relative distance, because it is determined on the 
localization of 90% of the positive nuclei, while the maximum value is based on the position of 
only one positive nucleus. 
Statistics 
A commercially available statistical software package (NCSS, Number Cruncher Statistical 
System) was used to compute the Pearson correlation coefficients (r) and their significance 
levels (p). The mutual correlations of the different proliferation-associated parameters were 
considered, as well as the correlations between the grade of cervical epithelial lesions and the 
proliferation associated parameters 
NCSS was also used to perform a stepwise linear discnminant analysis to select the best 
discriminating proliferation parameters and to obtain a linear discriminant classification of 
normal cervical epithelium, CIN1, CIN2, and CIN3 lesions, based on the selected best 
discriminating parameter. In the discnminant analysis, equal prior probabilities of 0 25 were 
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chosen, because these prior probalities are unknown. Choosing equal prior probabilities results 
in the best compromise between specificity and sensitivity. 
Figure 1. Indirect immunohistochemical staining of 3 μm. paraffin sections of cervical 
epithelium with MIB1. The peroxidase-labeled immunohistochemical complexes were 
visualized with diaminobenzidine (DAB)(brown-black). a. Normal cervical epithelium showing 
MIB1-positive nuclei exclusively in the basal cell layers, b. In a CIN3 lesion, MIB1-positive 
nuclei can be seen throughout the whole thickness of the epithelium, c. A selected field from a 
CIN3 lesion with the image analysis system d. The results of the RGB segmentation procedure 
with the VIDASF'"S image analysis system in the same CIN3 lesion. Positive nuclei are outlined 
with a red line and negative nuclei with a green line. 
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Results 
The indirect immunoperoxidase staining procedure with MIBI gave excellent staining results in 
the Κι-67-expressing nuclei, with hardly any background staining In normal and squamous 
metaplastic epithelium, MIBI-positive nuclei were most often found in the basal and parabasal 
cells In the CIN lesions, both the fraction of M IBI-stained nuclei and the height of posively 
stained nuclei increased progressively with the grade of the CIN lesion (Figures 1a and b). 
MIB1- stained non-mitotic cells were always found at higher levels than the most superficially 
located mitotic figures 
Each "positive-negative" manufactured image was compared by the operator with the 
corresponding field in the immunostamed slide. With the RGB segmentation procedure, it 
appeared that almost all of the MIBI-positive and MIBI-negative nuclei were correctly 
recognized by the automatic image analysis system. In general, only minimal interactive 
interventions were necessary (Figures 1c and d) 
Table 1. Results of computerized analysis of MIBI positivity in normal cervical 
epithelium and CIN1-3 
Diagnosis 
Normal cervix 
CIN1 
CIN2 
CIN3 
r-value 
No Of 
Cases 
5 
5 
7 
5 
Fractpos3 
mean±SD 
0.075+0.031 
0.161 ±0.026 
0 246±0.060 
0 393±0.060 
0.92 
(p<0.0001) 
Poslength" 
meantSD 
0 036±0.013 
0 084±0.013 
0.178±0.054 
0.445±0 037 
0 90 
(p<0 0001) 
Reldist90c 
mean±SD 
0 150±0 051 
0.324±0.060 
0.510±0 070 
0 846±0.045 
0.97 
(p<0.0001) 
Reldist max" 
mean±SD 
0 199±0 088 
0 460±0.096 
0 769+0.067 
0.980±0.016 
0 96 
(p<0.0001) 
a
 Fractpos fraction of MIBI positively stained nuclei (Ki-67 labelling index). 
b
 Poslength' number of positively stained nuclei per unit length of basement membrane 
c
 Reldist90: ninety percentile value of the relatk/e distance. 
d
 Reldist max: maximum value of the relative distances of positive nuclei to the basement 
membrane, 
r-value = correlation coefficient, 
ρ = significance level of r. 
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The mean values and standard deviations of the proliferation-associated parameters for 
normal cervical epithelium, CINI, CIN2, and CIN3 lesions are given in Table 1 The values of 
the 4 proliferation-associated parameters for the individual cases in this study are 
represented graphically in Figures 2a-2d Table 1 and Figures 2a-2d show that the values of 
all the proliferation- associated parameters increased with increasing grade of the CIN lesion. 
In CIN3 lesions, the fraction of Ki-67 antigen-expressing cells was approximately 40% and 
2 5 times greater than in CIN1 lesions Fractions of Κι-67-expressing cells exceeding 25% 
were exclusively found in CIN2 and CIN3 lesions. In normal cervical epithelium, the highest 
MIB1-positive nuclei were found in the basal third of the epithelium, in CIN1 lesions, the 
highest MIBI-positive nuclei were noticed in the middle third of the epithelium, and in CIN2 
and CIN3 lesions, the highest MIB1- positive nuclei were found in the upper third of the 
epithelium (Figure 2d). 
In CIN3 lesions, the highest MIBI-positive nuclei were invariably found in the most superficial 
layers of the epithelium, with a relative distance from the basement membrane greater than 
0.95. Correlation analysis revealed that all proliferation-associated parameters were highly 
correlated (r>0.90, p<0 0001) with the agreed histomorphological grade of the dysplastic 
changes in cervical epithelium (Table 1) The highest correlations (r>0 96, p<0.0001) were 
found for the maximum value and the 90th percentile of the relative distances of MIBI-stained 
nuclei from the basement membrane (Table 1) Correlation analysis also disclosed that the 
proliferation associated parameters were mutually correlated (0 82<r<0 99, p<0.001) 
In a stepwise linear discriminant analysis, including the four proliferation-associated 
parameters, the 90th percentile of the relative distances of MIB1-positive nuclei was selected 
as the best discriminating parameter to classify the cervical epithelium as normal, CIN 1, CIN 2 
or CIN 3. Because the proliferation-associated parameters are mutually strongly correlated, 
only univariate discriminant classifiers were considered With a univariate discriminant 
classifier, based on 90th percentile of the relative distances, all cases were correctly classified. 
Using the other proliferation parameters in univariate linear discriminant classifiers resulted in 
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some misdassifications: for instance, the classifier based on the maximum value of the relative 
distances gave rise to one misclassification of a normal case as CIN1 (Figure 2d) 
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Figure 2. MIB1 positivity in normal cervical and CIN1-3 epithelia. Relation between four 
features of MIB1 positivity and the degree of CIN. a. Positive fraction (Fractpos) in normal 
cervical and CIN1-3 epithelia. b. Number of positive nuclei per unit length of basement 
membrane (Poslength). c. 90-percentile value of the relative distances, d. The maximum value 
of the relative distances of positive nuclei from the basement membrane. 
Discussion 
The results of this study have shown that automatic image analysis systems can be used to 
recognize proliferating and non-proliferating cells in normal and dysplastic cervical epithelium in 
formalin-fixed and paraffin-embedded archival material, using the monoclonal antibody M IBI. 
The KI-67 labelling index, the relative distances of the Ki-67 antigen-expressing nuclei from the 
basement membrane, and the number of cycling cells per unit length of basement membrane 
could easily and rapidly be determined and gave detailed numerical information on proliferative 
intraepithelial abnormalities. 
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All of our quantitative parameters reflecting the proliferative activity and location of the 
proliferating cells within the cervical epithelium were highly correlated with the 
histomorphological grade of the dysplastic changes (r>0 90, p<0 0001) The highest 
correlations were found for the maximum value and the 90th percentile of the relative distances 
of MIB1-positive stained cells from the basement membrane (r>0 96, p<0 0001). Using the 
latter proliferation parameter in a univariate linear discriminant classifier for grading for 
dysplastic changes in the cervical epithelium, no discrepancies were found with the 
histomorphologic classifications (normal, CIN1, CIN2, and CIN3) 
Our results are in complete agreement with those recently obtained by a semi-quantitative 
grading system of CIN lesions, based on the highest level at which a mitotic figure was seen in 
the epithelium (6). The mitosis grade, ranging from 0 to 3, was highly correlated with the 
histomorphological grade of the CIN lesion (r=0 96, p<0.001) and there was a 93% accordance 
of mitosis graded and histomorphologically graded CIN lesions (6) In the latter study, PC10, a 
commercially available monoclonal antibody recognizing the proliferating cell nuclear antigen 
(PCNA), was also used for immunohistochemical visualization of the proliferating cells in 
formalin-fixed and paraffin-embedded cervical specimens PCNA staining was graded in a 
manner similar to the mitotic grade; grade 0 was assigned if no PCNA staining was detected or 
if the PCNA-positive nuclei were limited to the basal layer and the grades 1, 2, and 3 were 
assigned when the highest PCNA-positive nuclei fell in the lower, middle, or upper third of the 
epithelium, respectively In comparison to the mitosis grading system, PCNA grading 
correlated less well with the histomorphological grading of the dysplastic changes (r=0 75, 
p<0.001) and accordance between PCNA grade and histomorphological grade was obtained in 
only 45% (31/68) of the cervical tissue specimens investigated A plausible explanation for this 
poor accordance is that the arbitranly chosen PCNA grading system was not suitable for the 
classification of CIN lesions. Indeed, if we had used a comparable grading system, based on 
the thirds of the epithelium wherein the highest MIB1-positive nuclei were situated (see Figure 
2d) we also would have found a poor accordance with the histomorphological grades, because 
all our CIN 1 lesions would have been classified as CIN2, all our CIN2 lesions as CIN3, and 
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some of the normal specimens as CIN 1 Shurbaji et al (6) found PCNA grades exceeding the 
CIN grades in 37 % of their cases and in 18% of their cases the PCNA grade was lower than 
the CIN grade. The latter observation especially could not be well explained by the authors, but 
possible explanation may be found in their choice of PC10 to visualize cycling cells The 
complexities of the use of monoclonal antibodies recognizing PCNA were recently reviewed by 
McCormick and Hall (8) and the supenoty of MIB1 in companson to PC10 was demonstrated 
more recently by the same investigators (9). In the latter study they demonstrated that PC10 
stained not only the proliferating cells, but also non-cycling cells and that the fraction of positive 
stained cells is dependent on the dilution of PC10 used in the immunohistochemical procedure. 
These shortcomings were not found for the MIB1 monoclonal antibody and it was concluded 
that MIB1 is superior to PC10 for quantifying proliferative activity. Furthermore, differences and 
fluctuations in fixation conditions have considerable effects on the immunoreactivity of PC10, 
which can, for instance, be reduced by prolonged fixation (15). Recently Casasco et al. (16) 
have demonstrated that the loss of PC 10 immunoreactivity in formaldehyde-fixed tissues is 
progressive and already quantifiable after 3 h fixation In particular, fixation times of more than 
6 h resulted in a considerable reduction of the PC10- positive cell fraction 
In this study we found that all dysplastic changes in cervical epithelium were accompanied by 
an increased proliferative activity, as defined by the Ki-67 labelling index (LI) In CIN2 and CIN3 
lesions, the Ki-67 Lis were 25% and 40%, respectively Such high Ki-67 Lis are most 
frequently described in rapidly proliferating malignant tumors (17,18) In many malignant 
tumors, lower Ki-67 Lis were found than in our present study set of CIN2 and CIN3 lesions (19-
21) In well, moderately, and poorly differentiated squamous cell carcinomas of the cervix, the 
mean Ki-67 Lis were 22.7, 27.0 and 24 2% respectively (21) The Ki-67 Lis we found m CIN2 
and CIN3 were comparable to or even greater than those found in cases of invasive 
carcinomas of the cervix. In spite of the high proliferative activity in CIN lesions, it is well known 
that invasive squamous cell carcinoma will develop in only a fraction of these (22) It is likely 
that the high proliferative activity in CIN is controlled by regulating genes and/or proteins. The 
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control mechanisms preventing progression of CIN to invasive squamous cell carcinomas have 
to be elucidated in more appropnate and informative studies 
We conclude that our results support the theory that cervical intraepithelial neoplasia involves a 
progressive dysfunction of the proliferative activity of cervical epithelial cells As a 
consequence, the use of MIB1, especially in combination with image analysis offers a 
promising alternative method for the objective, reproducible, and reliable classification of 
dysplastic changes in the cervical epithelium Finally, the image analysis procedure presented 
here can also be used to assess differences in the expression of other nuclear proteins 
involved in cell cycle regulation in the cervical epithelium, such as oncogene and tumor 
suppressor gene proteins. 
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Summary 
Papanicolaou-stained cervical smears (Pap smears) of post-menopausal women often 
present difficulties in distinguishing atrophic cervical epithelium from high-grade cervical 
intraepithelial neoplasia (CIN2-3) The aim of this study was to disclose differences in 
proliferative activity in normal cervical epithelium, cervical atrophy, and high-grade CIN 
lesions, in order to develop specific and sensitive classifiers to discriminate between cervical 
atrophy and high-grade CIN, both in cervical smears and in tissue sections A case-control 
study was done on 83 patients. The proliferative activity was assessed in histological 
sections using the monoclonal antibody MIB1 An image analysis system was used to 
characterize different proliferation-associated features. Preceding Pap smears were 
restamed with MIB1 and proliferative activity was measured with a point-counting procedure, 
carried out on a training set of 32 cases and a test set of 51 cases. In cervical atrophy, the 
proliferative activity was significantly lower than in normal epithelium (p<0.001). The 
proliferative activity measured in both biopsies and cervical smears was considerably higher 
in high-grade CIN than in normal epithelium (p<0 001). Discriminant analyses resulted in four 
classifiers, based on proliferation parameters, to discriminate between cervical atrophy and 
high-grade CIN, and between CIN2 and CIN3, in biopsy specimens and cervical smears, 
respectively The two classifiers for biopsy specimens resulted in 100% correct 
classifications. Application of the classifier obtained from the training set of Pap smears 
resulted in 100% correct classifications of the Pap smears in the test set The classifier to 
discriminate between CIN2 and CIN3 in Pap smears, obtained from 36 patients, resulted in 
87% and 90% correct classifications, respectively 
Key words: CIN, cervical atrophy; Ki-67, MIB1; immunohistochemistry, Pap smears; 
quantitative analysis. 
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Introduction 
In cervical smears or biopsies, taken from post-menopausal women, considerable diagnostic 
difficulties may be encountered to distinguish atrophy from high-grade CIN (CIN2-3) In 
cervical atrophy, the epithelium is thin and epithelial maturation is markedly reduced The 
atrophic epithelial cells may resemble the cells in high-grade CIN lesions (1,2) In present-
day clinical practice, a cervical smear that contains cell groups that cannot be classified as 
either atrophy or high-grade CIN will be repeated after a course of oral or local estrogen 
therapy (3-7) Due to estrogenic response, the atrophic epithelial cells will mature into normal 
superficial cells, while abnormal epithelial cells in CIN lesions will not change (3) 
Recent immunohistochemical studies with the proliferation-associated monoclonal antibody 
MIB1 have shown the potential value of this antibody in discriminating between normal 
cervical epithelium and CIN lesions in tissue sections (8-10). These studies showed that the 
number and distribution of Ki-67 positive cells correlated well with the grade of CIN. The Ki-
67 labelling index (LI) is low in normal cases and gradually increases with CIN (8-11) 
Some authors have reported decreased expression, or even absence of MIB1 positivity in 
cervical atrophy; MIB1 (re)staining of Pap smears and/or biopsies with atrophy and possible 
CIN could therefore be of great practical value (9,12,13).The finding of a very low Ki-67 LI 
would resolve this problem and would reduce the number of follow-up procedures (13) 
In this study, cervical biopsies and Pap smears containing normal cervical epithelium, 
cervical atrophy, CIN2, and CIN3 were used for a MIB1 (re)staining procedure. The aims of 
this study were three-fold: 1) to assess cell proliferation activity in cervical biopsies and Pap 
smears of women with cervical atrophy, with high-grade CIN and normal cervical epithelium; 
2) to define reliable classifiers, based on proliferation-associated parameters, to discriminate 
between atrophy and high-grade CIN lesions in both cervical biopsies and Pap smears; and 
3) to construct a diagnostic decision tree that can be used to reduce the number of additional 
follow-up smears to discriminate between cervical atrophy and high-grade CIN. 
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Materials and methods 
Patients 
In this case-control study, 83 patients with cervical atrophy, or high-grade CIN, or cases with 
normal cervical epithelium, were retrieved from the files of the University Hospital of 
Nijmegen The following inclusion criteria were used Patients with cervical atrophy were 
above the age of 50 years and had no CIN in history or follow-up All diagnoses of Pap 
smears from patients with high-grade CIN were confirmed by histology Histo- and 
cytopathological diagnoses were made independently by two pathologists on routinely HE 
stained sections and Pap smears, respectively. In cases of disagreement, a consensus was 
reached with a third pathologist 
The 83 patients were subdivided in two different groups. Group I consisting of 32 women 
who had had a Pap smear and subsequent histology, including five cases with CIN2, five 
cases with CIN3, ten cases with cervical atrophy and twelve cases without cyto- or 
histopathological abnormalities. In this group, proliferative activity was studied in both 
cervical biopsies and cervical smears. Group I was used as a training set in order to 
construct classifiers to discriminate between cervical atrophy and high-grade CIN in both 
cervical biopsy specimens and cervical smears. In addition, this group was also used to 
construct classifiers to discriminate between CIN2 and CIN3 in the patients with high- grade 
CIN Group II consisting of 51 women with Pap smears only, including 25 cases with cervical 
atrophy and 26 cases with high-grade CIN (10 CIN2 and 16 CIN3). The proliferative activity 
was assessed in cervical smears only This group of patients was used as a test set to 
validate the classifiers for cervical smears, obtained from the training set Subsequently, the 
data of group II were used to extend the series of patients, in order to refine the 
aforementioned classifiers for cervical smears. The refined classifier to discriminate between 
cervical atrophy and high-grade CIN was used to construct a diagnostic decision tree 
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Immunohistochemistry 
From each case of group I, a 3 μιη thick parallel section was stained using the monoclonal 
antibody MIB1 according to a previously described protocol (8) The MIB1 staining protocol 
for tissue sections was slightly modified for the restaining of Pap smears. The cover slides 
were removed in xylene overnight and rinsed in methanol during a few seconds. 
Endogenous peroxidase was blocked using HzC^m methanol for 15 minutes and the slides 
were rinsed three times in phosphate-buffered saline (PBS, pH 7 4) for 5 mm The slides 
were placed in a citrate buffer (0.01 M, pH 6.0), heated in a household microwave oven (3 
mm at 850 W until boiling, followed by 10 mm at 150 W), and then cooled down to room 
temperature (RT) Subsequently, the slides were rinsed in PBS (3 times, 10 mm), incubated 
with MIB1 (Immunotech S.A., France) 1.100 in PBS with 1% bovine serum albumin overnight 
at 40C, and with rabbit anti-mouse peroxidase (Dakopatts, Denmark) 1 100 in PBS (60 mm, 
RT) The peroxidase-labelled complex was visualized with diaminobenzidme and intensified 
with 5% CUSO4 (5 mm, RT). All incubation steps were followed by three washes of 5 mm in 
PBS Subsequently, the slides were counterstained with Mayer's haematoxylin, dehydrated, 
and mounted. 
Image analysis in tissue sections 
MIB1 positivity in the histological slides of the biopsies was measured using a VIDAS'"115 
image analysis system (Kontron Ine, Germany) as previously described (8) Using the 
VIDAS plus system, four proliferation-associated parameters were measured the fraction of 
MIBI-positive nuclei (Ki-67 LI); the number of MIB1-positive nuclei per unit length of 
basement membrane (Poslength); the maximum value of the relative distances of MIB1-
positive nuclei from the basement membrane (Reldistmax); and the 90th percentile of the 
relative distances of MIB1-positive nuclei from the basement membrane (Reldist90). 
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MIB1 positive cell counting in smears 
The MIB1- restamed Pap smears were evaluated using a lOOx oil immersion objective The 
presence of three dimensional cell groups in cervical smears makes it impossible to 
determine reliable the Ki-67 LI of an individual cell group Therefore, we used a 36-points 
Merz-graticule (type GM1, Leica), placed in one of the ocular tubes of the microscope The 
graticule was projected over a coherent group of squamous epithelial cells and all graticule 
points hitting the cell group were counted Subsequently, all graticule points hitting MIB1-
stained nuclei in the same cell group were scored The proliferative activity index (PAI) is 
defined as the fraction of graticule points falling on MIB1 positive nuclei and the cell group 
Only squamous epithelial cell groups with 20 or more cells were used for evaluation At least 
10 coherent squamous epithelial cell groups with the highest MIB1 positivity were evaluated 
in each restamed Pap smear 
Statistics 
Univariate statistics 
A one-way analysis of variance (ANOVA) was performed to assess the differences in 
proliferative activity in normal epithelium, cervical atrophy, CIN2, and C1N3. The Kolmogorov-
Smirnov test was used to assess whether the proliferation-associated parameters are 
Gaussian distributed When significant differences between these diagnostic entities were 
found by ANOVA, tests were used to determine which groups were mutually different The 
modified least significant difference (LSD) test according to Bonferroni was used when the 
group variances were equal; otherwise Tamhane's T2 test was chosen. 
Multivariate statistics 
A stepwise linear discriminant analysis was performed on the proliferation-associated 
parameters obtained from the biopsy specimens of the group I patients (=training set), in 
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orderte select the best feature to discriminate between cervical atrophy and high-grade CIN 
lesions Subsequently, the same procedure was used to select the best feature to allocate 
patients with high-grade CIN to CIN2 and CIN3, respectively. Discriminant analysis was also 
used to construct two discriminant functions The first discriminant function (DFH1) 
represented a classifier for histological sections to predict whether a patient has cervical 
atrophy or a high-grade CIN lesion. The second discriminant function (DFH2) will be used to 
classify patients with a high-grade CIN lesion into either CIN2 or CIN3 Equal prior 
probabilities of 0.5 were used in both discriminant analyses 
The data of the group I patients (=training set) were used to construct the discriminant 
functions for cervical smears that were subsequently used to classify the patients in the 
group of cervical atrophy and high-grade CIN (DFC1), and to subdivide the latter patients into 
CIN2 or CIN3 (DFC2) 
The same patients were used both to obtain the classifiers and to assess the reliability of the 
classification results of these classifiers The classification results may therefore be 
optimistically biased. The 'leave-one-out' cross-validation procedure was used in the linear 
discriminant procedures to reduce this bias. The PAI-values obtained from the group II 
patients (=test set) were used for a further validation of the classifiers DFC1 and DFC2, and 
to obtain more refined classifiers based on a larger series of patients 
The refined classifier DFC1 was used in a linear logistic regression model to estimate the 
posterior probability in order to construct a diagnostic decision tree for post-menopausal 
women with smears in which it was not possible to make the diagnosis cervical atrophy or 
high-grade CIN The posterior probability is defined as the conditional probability that a woman 
has high-grade CIN, given the value of DFC1. This posterior probability is given by the formula 
P(high-grade C I N | D F C 1 ) = EXP(DFC1) / (1 + EXP(DFC1)). The aim of such a diagnostic 
decision tree is to limit the number of women participating in screening programs who needed 
a repeated Pap smear after administration of estrogens for 1 week in order to reach a definite 
diagnosis All statistical analyses were performed with SPSS 8 0 for Windows 
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Results 
MIB1 stained histological sections (group I patients) 
In normal cervical epithelium, the MIB1-positive cells were observed in the basal and 
parabasal cell layers (Figure 1A) The proliferative activity was lower in cervical atrophy than 
in normal epithelium but MIB1-positive cells were found at higher positions within the 
epithelium (Figure 1B) In high-grade CIN lesions, a higher proliferative activity was found 
than in atrophic and normal cervical epithelium, and the proliferative activity increased with 
the grade of the CIN (Figures 1C and 1D) 
The lowest values of Ki-67 LI were found in the group of patients with cervical atrophy, and 
the Ki-67 LI in cervical atrophy differed significantly from those of normal and dysplastic 
epithelium (Table 1) The parameters associated with the relative distances of Ki-67 positive 
nuclei are significantly greater in cervical atrophy than in normal cervical epithelium (Table 
1) Both these distances and Ki-67 LI increased with increasing grade of CIN, and the 
differences between CIN2 and CIN3 were highly significant (Table 1) 
Ki-67 LI was selected as the best parameter to discriminate between cervical atrophy and 
high-grade CIN in histological sections The discriminant function (DFH1) is given by DFH1 = 
Bo + Β, χ Ki-67 LI, and the constant term (Bo) and the coefficient of Ki-67 LI (B^ are given in 
Table 2 A cervical lesion was classified as high-grade CIN if Ki-67 LI > 0 17 and as cervical 
atrophy if Ki-67 LI < 0 17 Using this classifier, all 10 cases with cervical atrophy and all 10 
cases with high-grade CIN of group I were correctly classified None of the 12 control 
subjects of group I was classified as high-grade CIN 
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Figure. 1. Indirect immunoperoxidase staining procedure of 3 μπ. paraffin sections of 
cervical epithelium with MIB1. The peroxidase-labelled immunohistochemical complexes 
were visualised with diaminobenzidine (DAB) (brown-black). (A) Normal cervical epithelium, 
showing MIB1-positive nuclei in the basal and parabasal cell layers. (B) In atrophic cervical 
epithelium, the number of MIB1-positive nuclei is much lower than in normal cases. Positively 
stained nuclei can also be seen in the middle third of the epithelium. (C) In a CIN2 lesion, the 
positive fraction and the height of MIB1-positive nuclei progressively increase. (D) CIN3 
epithelium, showing high numbers of MIB1-positive nuclei throughout the whole thickness of 
the epithelium. 
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Table 1. Results of the measurements of proliferation-associated parameters in 
MIB1- stained biopsy specimens and MIB1-restained Pap smears in the 
group I patients (=training set). 
Histology Cytology 
Diagnosis Ν Κι-67 LI Poslength ReldistSO Reldistmax PAI VPAI 
mean ± SD Mean ± SD Mean ± SD Mean ± SD mean ± SD mean ± SD 
Group I 
Normal 
cervix 
Atrophy 
CIN2 
CIN3 
PI 
P2 
P3 
P4 
P5 
P6 
32 
12 
10 
5 
5 
0 07 ± 0 01 
0 02 ± 0 01 
0 25 ± 0 05 
0 41 ±0 05 
<0 001 
<0 001 
<0 001 
<0 001 
<0 001 
<0 001 
0 05 ± 0 01 
0 01 ±0 01 
0 18 ±0 07 
0 43 ± 0 03 
0 05 
<0 001 
<0 001 
<0 001 
<0 001 
<0 001 
0 15 ±0 04 
0 33 ±017 
0 50 ± 0 06 
0 85 ± 0 05 
0 003 
<0 001 
<0 001 
004 
<0 001 
<0 001 
0 20 ± 0 06 
0 37 ±0 17 
0 76 ± 0 08 
0 98 ± 0 02 
0 003 
<0 001 
<0 001 
<0 001 
<0 001 
0 01 
0 01 ± 0 02 
0 04 ± 0 02 
0 34 ± 0 07 
0 59 ± 0 07 
0 14 
<0 001 
<0 001 
<0 001 
<001 
<0 001 
0 09 ± 0 08 
0 18 ±0 06 
0 58 ± 0 06 
0 77 ± 0 04 
0 02 
<0 001 
<0 001 
<0 001 
<0 001 
0 001 
P1 = P-values for the difference between the group of normal cervical epithelium and the group of cervical 
atrophy 
P2 = P-values for the difference between the group of normal cervical epithelium and the group of CIN2 
P3 = P-values for the difference between the group of normal cervical epithelium and the group of CIN3 
P4 = P-values for the difference between the group of cervical atrophy and the group of CIN2 
P5 = P-values for the difference between the group of cervical atrophy and the group of CIN3 
P6 = P-values for the difference between the group of CIN2 and the group of CIN3 
PAI = proliferative activity index of MIB1 reslamed Pap smears 
Ki-67 LI = fraction of MIB1-positive nuclei 
Poslength = number of MIB1-positive nuclei per unit length of basement membrane 
Reldist90 = 90th percentile of the relative distances of MIB1-positive nuclei from the basement membrane 
Reldistmax = maximum value of the relative distances of MIB1-positive nuclei from the basement membrane 
The ReldistSO, measured in biopsy specimens, appeared the most appropriate feature to 
discriminate between CIN2 and CIN3 The constant term (Bo) and the coefficient (B^of the 
discriminant function DFH2 are given in Table 2 A high-grade CIN lesion was classified as 
CIN3 if ReldistSO > 0 67 and as CIN2 if Reldist90< 0 67 Using this classifier, all 10 women 
with a high-grade CIN were correctly classified as CIN2 or CIN3 The "leave-one-out" cross-
validation procedure for DFH1 and DFH2 did not disclose differences in the classification 
results 
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MIB1 restained pap smears (group I patients) 
The indirect immunoperoxidase staining procedure with MIB1 for Pap smears gave very 
good and constant staining results. Abnormal squamous epithelial cell groups displayed 
numerous positive dark brown nuclei (Figure 2A) Normal superficial and intermediate 
epithelial cells did not stain at all Abnormal squamous epithelial cell groups could be easily 
distinguished within the restained Pap smear on the basis of strong immunohistochemical 
reactivity combined with abnormal nuclear morphology In the epithelial cell groups m smears 
of the control subjects and patients with cervical atrophy, MIB1-stained nuclei were sparsely 
observed (Figure 2B) The coherent cell groups in the cervical smears of patients with CIN2 
or CIN3 showed considerably larger numbers of MIB1-stained nuclei 
Table 2. The linear discriminant functions and classifiers for the differential 
diagnosis of cervical atrophy or high-grade CIN and for the subdivision of 
high-grade CIN into CIN2 or CIN3, based on measurements in MIB1 -stained 
biopsy specimens and MIB1-restained Pap smears obtained from the group 
I patients (=training set). 
DF B0 Bi Parameter Classifiers and the cross-validated classification 
results of these classifiers. 
DFH1 -11 174 64 475 Ki-67 LI High-grade CIN if Ki-67 LI > 0 17 and cervical atrophy if 
Ki-67LI<0 17 
All 20 cases with cervical atrophy or high-grade CIN were 
correctly classified None of the 12 control subjects were 
classified as high-grade CIN. 
DFH2 -88 011 130 483 Reldist90 CIN3 if Reldist90 > 0.67 and CIN2 if Reldidist90 < 0 67 
All 10 cases with high-grade CIN were correctly classified 
as CIN2 and CIN3, respectively 
DFC1 -27 623 64 379 VPAI High-grade CIN if VPAI > 0 42 or PAI > 0 18 
Cervical atrophy if VPAI < 0 42 or PAI < 0 18 
All 20 cases with cervical atrophy or high-grade CIN were 
correctly classified 
DFC2 -45 467 67 446 VPAI CIN3 if VPAI > 0 67 or PAI > 0 45 
CIN2 if VPAI < 0.67 or PAI < 0 45 
All cases of CIN2 and CIN3 lesions were correctly 
classified 
The discriminant function (DF) is given by the formula: DF = Bo+ Β, χ Parameter The 
diagnostic threshold values for the parameters given in the table were obtained from the 
equation DF=0. 
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Figure 2. Indirect immunohlstochemical restalning of Papanicolaou stained cervical 
smears with MIB1. (A) Cell group in a cervical smear of a patient with CIN3, showing a high 
fraction of MIB1-positive nuclei. (B) Cervical smear of a patient with cervical atrophy, 
displaying cell groups with sporadically MIB1-positlve nuclei. 
The Kolmogorov-Smirnov test revealed that PAI does not display a Gaussian distribution in 
cervical atrophy. Since, a Gaussian distribution was found after a square root transformation, 
VPAl instead of PAI was used in ANOVA and discriminant analysis. ANOVA disclosed that 
VPAl in the smears of the group I patients with cervical atrophy was significantly greater than 
in the control group (Table 1). In the CIN3 group, PAI andVPAl were significantly greater 
than in the CIN2 group (Table 1). 
The constant term and the coefficient forVPAl of discriminant function DFC1 are given in 
Table 2. A cervical lesion can be classified as a high-grade CIN if VPAl > 0.42 (PAI > 0.18) 
and as cervical atrophy if VPAl < 0.42 (PAI < 0.18). Using the DFC1 classifier, all 20 cases of 
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Group I were correctly classified as cervical atrophy or high-grade CIN. 
Linear discriminant analysis performed on the data of the patients with high-grade CIN 
resulted in a discriminant function (DFC2) to classify the lesion as CIN2 or CIN3 (Table 2) 
The diagnosis of CIN3 is made if VPAI > 0.67 (PAI > 0.45) and CIN2 if VPAI < 0 67 (PAI < 
0 45). Using this classifier, all cases with CIN2 (100%) and all of cases with CIN3 (100%) 
were correctly classified The "leave-one-out" cross-validation procedure for DFC1 and DFC2 
resulted in the same classification results 
Table 3. PAI and VPAI values in MIB1-restained Pap smears of group II 
patients (=test set). 
Diagnosis Ν PAI VPAI 
mean + SD mean ± SD 
Group II 51 
Atrophy 25 0 03 + 0 03 
CIN2 10 0 32 ±0.06 
CIN3 16 0 47 ± 0 04 
P4 < 0 001 
P5 < 0.001 
P6 <0 001 
Abbreviations are the same as given in Table 1 
MIB1 restai ned pap smears (group II patients) 
In the smears of the group II patients (=test set) we found comparable results for PAI andVPAl 
to those in the smears of group I patients (Table 3). Application of the classifier DFC1 obtained 
from the training set on the cases of the test-set disclosed that all 25 cases of cervical atrophy 
and all 26 cases with high-grade CIN were correctly classified by DFC1. Use of the classifier 
DFC2 in order to subdivide the patients with high-grade CIN of the test set into CIN2 and CIN3, 
respectively, resulted in 100% correct classifications of the CIN2 lesions and 75% correct 
classifications of the CIN3 lesions. The overall percentage of correct classifications of the 
DFC2 classifier in the test set was 84% 
0.17 + 0 08 
0.57 ± 0 05 
0 68 ± 0 03 
< 0.001 
< 0 001 
< 0.001 
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Table 4. The refined discriminant functions and classifiers for the differential 
diagnosis of cervical atrophy or high-grade CIN and for the subdivision of 
high-grade CIN into CIN2 or CIN3, based on measurements of PAI in MIB1-
restained Pap smears of all 71 cases of group I (=training set) and group II 
(=test set). 
DF BQ Bi Paramele Classifiers and the cross-validated classification 
results of these refined classifiers. 
DFC1 -32.081 77 754 VPAI High-grade CIN if VPAI > 0 41 or PAI > 0 17 
Cervical atrophy if VPAI < 0 41 or PAI < 0 17 
All 71 cases with cervical atrophy or high-grade CIN 
were correctly classified. 
DFC2 -35 199 55.031 VPAI CIN3 if VPAI > 0.64 or PAI > 0 41. 
CIN2 if VPAI < 0 64 or PAI < 0 41. 
13/15 (=87%) of CIN2 lesions and 19/21 (=90%) of 
CIN3 lesions were correctly classified 
The discriminant function (DF) is given by the formula: DF = Bo+ Β, χ Parameter The 
diagnostic threshold values for the parameters given in the table were obtained from the 
equation DF=0 
The data from all 71 smears of group I and II with cervical atrophy and high-grade CIN 
resulted in more reliable estimates of the Bo and B, of the discriminant functions DFC1 and 
DFC2 These refined estimates and classifiers are given in Table 4 Comparison of Tables 2 
and 4 disclosed that the threshold value of the PAI value to classify a cervical lesion as 
cervical atrophy or high-grade CIN was hardly influenced by the addition of 51 new patients 
This change of the threshold did not alter the classification results. Using this refined 
classifier, all cases of cervical atrophy and high-grade CIN were correctly classified The 
"leave-one-out" cross-validation procedure gave the same classification results 
Companson of the Tables 2 and 4 disclosed a statistically significant (p=0 002) relative 
change of 8.9% in the threshold value of PAI to subdivide high-grade CIN lesions into CIN2 
or CIN3 due to the addition of 26 new patients. The refined classifier DFC2 resulted in 13/15 
(87%) and 19/21 (90%) correct classifications in CIN2 and CIN3, respectively (Table 4). The 
"leave-one-out" cross validation procedure resulted in the same classification results 
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Diagnostic decision tree for post- menopausal women 
The refined discriminant function DFC1= -32 081 + 77.754 χ VPAI was used in a logistic 
regression model to determine the threshold values of PAI which were given in the diagnostic 
decision tree of Figure 3. The threshold values PAI < 0 1 and PAI > 0.25 were obtained by 
solution of the inequalities P(high grade CIN | D F C 1 ) < 0 001 and P(high grade CIN | DFC1) > 
0 999, respectively A posterior probability of 0 001 was chosen in order to minimize the risk 
that a woman with a high-grade CIN will be erroneously referred to the regular screening 
program A posterior probability of 0 999 was chosen to limit the number of women with 
cervical atrophy who will be directly referred to a gynecologist. The estimated frequency of 
women who need a repeat Pap smear after administration of estrogens prior to make a 
definite diagnosis is lower than 7.5%. 
Under the assumption that only the PAI values of the 71 women with cervical atrophy or 
high-grade CIN of this study were available, the results of application of the diagnostic 
decision tree on these women are as follows. Thirty-four women (48%) would have been 
referred to the regular screening program on the basis of PAI < 0 1 Four (6%) would have 
been advised to undergo a repeat Pap smear after administration of estrogens, and 33 
women (46%) would have been referred to a gynecological department because of a strong 
suspicion on a high-grade CIN lesion. None of the women who would have been referred to 
the regular screening program had high-grade CIN, and none of the women who would have 
been referred to a gynecologist had cervical atrophy Of the 4 women who had to be advised 
to have a repeat cervical smear, one had cervical atrophy and the other three had a CIN2 
lesion 
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Posf-menopausal woman 
in screening program 
NO 
YES 
Probability that patient has 
high grade CIN lesion 
<0.1%. 
The patent will be referred to 
the regular screening program. 
YES 
NO 
No further cytopathologic 
diagnostic procedures are 
needed 
YES 
New cervical smear after a 
hormone cure is needed for 
the definite diagnosis. 
NO 
Probability that patient has 
high grade CIN lesion 
> 99.9%. 
Patient should be referred to 
gynecology department 
Figure. 3 Diagnostic decision tree for post-menopausal women participating in cervical 
screening programs. 
Discussion 
To the best of our knowledge, this is the first study in which it has been shown that the Ki-67 
LI measured in histological sections and PAI measured in MIBI-restained Pap smears could 
be used to discriminate between cervical atrophy and high-grade CIN with 100% specificity 
and sensitivity. These results confirm the previous suggestions in the literature that 
measurements of the proliferative activity in MIBI-restained Pap smears could be of great 
practical value (12,13). 
Dunton et al. (14) found that Ki-67 immunostaining of cervical smears was a good predictor 
62 
of significant cervical pathology Patients with histological confirmed high-grade CIN (CIN2 
and 3) showed positivity in 89% of cases with their semi-quantitative scoring method of 
preceding MIB1-stained cervical smears However, these authors evaluated MIB1 
expression only in smears and did not study cases with cervical atrophy Recently, it was 
shown that MIB1 expression is useful in distinguishing dysplasia from atrophy in elderly 
women (15) These authors examined only cervical biopsies and reported extensive MIB1 
expression in the middle third of high-grade CIN epithelium, whereas atrophic epithelium 
displayed sporadic MIB1 positivity 
In a previous study we have shown that Ki-67 LI, and more specifically the parameter 
Reldist90 could be used to discriminate between CIN1, 2, and 3 lesions (8).The observation 
that the Ki-67 LI is highly correlated with the grade of CIN was confirmed in other studies (8-
11) In the present study, we found that the proliferation activity measured in cervical smears 
and defined by PAI could be used to construct a classifier to discriminate between CIN2 and 
CIN3 The percentages of correct classifications for this classifier were 87% and 90% for 
CIN2 lesions and CIN3 lesions, respectively 
In comparison with normal cervical squamous epithelium we found that cervical atrophy was 
characterized by decreased cell proliferation, whereas high-grade CIN was characterized by 
increased proliferation. In spite of the lower proliferative activity measured in histological 
sections of women with cervical atrophy, we found greater PAI values in the MIB1 restained 
Pap smears of the same women. This apparent contradiction could be explained by our 
observation that the mean value of the Reldist90 in the group of women with cervical atrophy 
(0.33) was double the mean value of this parameter in the group of women without epithelial 
abnormalities (0 15). 
The differences in proliferative activity between cervical atrophy and high-grade CIN may be 
explained by differences in the cell-cycle regulating mechanisms. It was shown that the gene 
product of the Rb gene (pRb) can be inactivated by the E7 proteins of oncogenic HPV, and 
that mactivation of pRb leads to hyperproliferation (16-19). Recently, it was shown that 
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malignant transformation of the ectocervical epithelium was associated not only with an 
abnormal expression of steroid receptors, but also with an elevated expression of the cell-
cycle regulating proteins cyclm, cyclm-dependent kinases and p53 (20) These findings 
suggested that the (pre-)neoplastic cells escape normal growth control and obtain active 
growth potential by aberrant expression of cell-cycle related factors (20) It seems likely that 
these differences in the cell cycle control will be preserved in cases where cytomorphological 
criteria failed to discern between cervical atrophy and high-grade CIN 
It is likely that our proposed decision tree will be useful to limit diagnostic procedures for 
women with cervical atrophy, and to limit a doctor's delay in treatment of women with high-
grade CIN lesions. Defining a serious decision error as the referral of a patient with high-
grade CIN to the regular screening program, we expect such an error in less than 1 of 1000 
post-menopausal women with a non-conclusive smear, while the expected reduction of 
cases who needed an estrogen cure is at least 90% These promising results have prompted 
us to extend our studies to another series of post-menopausal patients with Pap smears that 
were difficult to interpret, and the preliminary data confirmed the results of the present study 
We conclude that measuring of the proliferative activity in both histological sections of biopsy 
specimens and MIB1-restained Pap smears is a reliable procedure for differentiating 
between cervical atrophy and high-grade CIN In particular, MIB1 restaming of Pap smears 
looks to be a promising procedure in daily diagnostic practice 
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Abstract 
Objective 
Atrophic cervical epithelium of postmenopausal women may mimic high-grade cervical 
intraepithelial neoplasia (CIN2-3) in Papanicolaou-stamed cervical smears (Pap smears) 
Women with such an "atypical" Pap smear need a repeated Pap smear after a course of 
estrogens before a definite diagnosis can be made The aim of this study was to determine if 
measurement of proliferative activity in Pap smears of postmenopausal patients that were 
difficult to interpret is a reliable test to differentiate between cervical atrophy and high-grade 
CIN 
Methods 
Pap smears obtained before and after estrogen treatment of 30 postmenopausal women with 
an atypical Pap smear were restamed with the monoclonal antibody MIB1 to visualize 
proliferating cells The proliferative activity index (PAI) was subsequently measured in order 
to explore the feasibility of a recently proposed PAI-based diagnostic decision tree to reduce 
the number of estrogen courses and follow-up Pap smears in postmenopausal women. 
Results 
The PAI-based test to discriminate between cervical atrophy and high-grade CIN resulted in 
100% and 96% correct diagnoses in women with high-grade CIN and cervical atrophy, 
respectively. Only two of the 30 women would have needed a repeated Pap smear after 
estrogen treatment for definite diagnosis if the PAI-based diagnostic decision tree had been 
used. 
Conclusion 
Measurement of PAI in MIB1 restamed Pap smears is a simple, reliable, safe and probably 
also cost-effective method to obtain a substantial reduction of diagnostic estrogen courses 
and subsequent Pap smears in postmenopausal women with an atypical Pap smear. 
Key words: cervical atrophy; CIN; MIB1, estrogens, Pap smears. 
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Introduction 
Papanicolaou-stained cervical smears (Pap smears) with epithelial atrophy may present 
considerable cytodiagnostic problems Due to reduced levels of estrogen in postmenopausal 
women, atrophic squamous epithelium of the cervix shows substantially diminished 
maturation which may mimic dysplastic epithelium of high-grade cervical intraepithelial 
neoplasia (CIN2 and 3) (1-4) The differential diagnostic problem of such an "atypical" 
atrophic Pap smear in postmenopausal women is mostly attacked with advice to the 
gynecologist or general practitioner to repeat the Pap smear after a course of systemic or 
locally applied estrogens (5-7) The rationale for this approach is that, after administration of 
estrogen, atypical atrophic epithelium, in contrast to dysplastic epithelium, will mature into 
normal squamous epithelium This procedure works well in daily practice, but also has 
disadvantages In patients with high-grade CIN, this procedure gives a delay in treatment, 
whereas for women who ultimately have normal epithelium, the procedure results in a period 
of uncertainty and frequently in unnecessary follow-up Pap smears The procedure is 
unsuitable for patients with hormone-sensitive malignancies An alternative test of the 
available initial, nonconclusive Pap smear, which will enable the pathologist to directly 
discnmmate between atrophy and high-grade CIN in smears of postmenopausal women, 
might overcome these disadvantages. 
Several studies have shown the potential value of the proliferation-associated monoclonal 
antibody MIB1 to discern normal cervical epithelium from CIN (8 -11) In a recent study of 
Pap smears and biopsies we demonstrated that the proliferative activity measured in MIB1 
restamed Pap smears could be used to differentiate between normal atrophy and high-grade 
CIN (12) Application of a classifier to discriminate between atrophy and high-grade CIN 
based on the proliferative activity index (PAI) measured in MIB1 restamed Pap smears 
resulted in 100% correct classifications. We speculated that the high specificity and also the 
sensitivity of the classifier were based on the differences in the regulation of cell proliferation 
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and that, in cervical atrophy, in contrast to high-grade CIN, estrogens influenced cell 
proliferation (12) A diagnostic decision tree was proposed which might be used to reduce 
unnecessary estrogen courses and repeated Pap smears in women with an atypical atrophic 
Pap smear 
In the present study, Pap smears of postmenopausal women with an atypical atrophic Pap 
smear who underwent a second Pap smear after estrogen treatment for definite diagnosis 
were used for the MIB1 restainmg procedure The PAI values were measured in MIB1 
restamed Pap smears obtained before and after estrogen therapy 
The aim of this study was first to discriminate between atrophy and high-grade CIN in 
postmenopausal women with an atypical atrophic Pap smear by using the PAI-based 
classifier, and to assess the usefulness of the earlier proposed diagnostic decision tree. 
Second, the biological effects of estrogen therapy on the proliferative activity in atrophic 
epithelium and CIN were studied 
Materials and methods 
Patients 
In this retrospective study we selected 30 postmenopausal patients with an atypical Pap 
smear from the files of the department of Pathology of University Hospital. For these women 
it was not possible to give a definite diagnosis on the initial Pap smear, since the initial smear 
displayed not only atrophic cells, but also cells and/or cell groups that might have originated 
from a high-grade CIN lesion In all those women a short course of estrogen (7 days, two 2-
mg tablets of Synapause-Ea) had been given, followed by a second Pap smear for definite 
cytological diagnosis. On the basis of the cytological findings in the second Pap smear, a 
final diagnosis of cervical atrophy was made in 23 women and of high-grade CIN in 7 
patients. The diagnosis of high-grade CIN was confirmed by biopsy of the cervix The women 
who were diagnosed as having cervical atrophy had no CIN in history After definite 
diagnosis the 23 women with cervical atrophy were referred to the regular screening 
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program In a follow-up period of at least 5 years, 30 cervical Pap smears were taken and in 
none of these smears abnormalities were found 
Immunohistochemistry 
After removing the cover slides, the Pap smears taken before and after estrogen therapy, 
were rehydrated and restamed with an indirect immunoperoxidase technique using the MIB1 
mouse monoclonal antibody This antibody against the nuclear Ki-67 antigen is expressed in 
the G1, S and G2/M phase of the cell cycle Finally, the slides were slightly counterstained 
with Mayer's hematoxylin and subsequently dehydrated and mounted This restaining 
procedure has been described in detail elsewhere (12) This restaining does not require a 
destaming step In all cases with cervical atrophy, MIBI-positive endocervical cells and 
MIB1 -positive inflammatory cells can be found as internal control cells 
Evaluation of proliferative activity in MIB1 restained Pap smears 
MIB1 restained Pap smears were evaluated using a 100x oil immersion objective 
Measurement of the proliferative activity in MIB1 restained Pap smears was achieved by 
calculating the PAI as recently described (12) Briefly, restained smears were screened for at 
least 10 coherent squamous cell groups with 20 or more cells and with highest MIB1 
positivity A Merz graticule grid with 36 measuring points, placed in one of the ocular tubes, 
was projected over such a group. The number of grid points that hit the whole cell group and 
the number of points that hit only the MIB1 positively stained nuclei were scored From these 
two values a fraction can be calculated; this value will be called the proliferative activity index 
(PAI) in this study. The PAI values were measured in both the MIB1 restained initial Pap 
smears and the MIB1 restained Pap smears after the estrogen course The proportional 
changes (%) in PAI due to estrogen treatment were then calculated for each case 
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Post-fnenopausal woman 
in screening program 
NO 
NO 
NO 
Woman will be referred 
to 
gynecology department 
YES No further cytopathotogic 
diagnostic procedures 
are needed 
YES Woman will be referred 
to 
regular screening program 
YES Woman needs new smear 
after 
short estrogen course 
Figure 1. Previously proposed diagnostic decision tree for postmenopausal women 
participating in cervical cancer screening programs (12) 
PAI-based classifiers and diagnostic decision tree 
In our previous study on 71 women, including 35 women with cervical atrophy, 15 patients 
with CIN2 and 21 patients with CIN3, we obtained two classifiers for MIB1 restained Pap 
smears to discriminate between cervical atrophy and high-grade CIN and to subdivide high-
grade CIN lesions in CIN2 and CIN3, respectively Application of the former classifier 
resulted in a diagnosis of cervical atrophy if PAI < 0 17 and high-grade CIN if PAI > 0.17. The 
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latter classifier allocates a case of high-grade CIN as CIN2 if PAI< 0 41 and as CIN3 if PAI > 
0 41 (12) 
In addition, a diagnostic decision tree (Figure 1) had been proposed to reduce the number of 
postmenopausal women, who need repeated Pap smears after estrogen treatment for a 
definite diagnosis According to this decision tree a woman with a PAI < 0 1 should be 
referred to the regular cervical screening program with normal follow-up interval, because the 
probability that she will have high-grade CIN will be less than 0 1% A woman with a PAI 
>0 25 should be referred directly to the gynecological department for treatment, since the 
probability that she will have high-grade CIN is greater than 99 9 % Only postmenopausal 
women with a PAI between 0 10 and 0 25 should be advised to have a new Pap smear after 
an estrogen course (12) 
Results 
In the MIB1 restained Pap smears taken before hormone treatment, the squamous cell 
groups of cases ultimately diagnosed as cervical atrophy exhibited only a few positive nuclei, 
whereas the smears of patients with high-grade CIN showed cell groups with large numbers 
of M IBI-positive cells (Figures 2A-2B) 
The PAI values of the MIB1 restained Pap smears obtained before estrogen treatment are 
presented in Figure 3 This figure discloses that the PAI values are considerably lower in 
women with an ultimate diagnosis of cervical atrophy than in women with an ultimate 
diagnosis of high-grade CIN With the exception of one case, all women with cervical atrophy 
had PAI < 0 17 and all patients with high-grade CIN had PAI > 0 17 With the classifier to 
discriminate between CIN 2 and CIN3 in cases with high-grade CIN, all cases were correctly 
classified as CIN2 or CIN3 
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Figure 2. MIB1 restained Pap smears before estrogen treatment of a woman with cervical 
atrophy and a woman with CIN3. Indirect immunoperoxidase restaining procedure of Pap 
smears. The peroxidase-labelled immunohistochemical complexes were visualized with 
diaminobenzidine (black). Atrophic cervical epithelium (A) shows a sparse positive nucleus, 
whereas the epithelium In a CIN3 lesion (B) shows many MIB1-positive nuclei. 
Application of our proposed diagnostic decision tree (Figure 1) to the group of 30 
postmenopausal women with an atypical Pap smear discloses that only two women would 
have been advised to have a new Pap smear after estrogen treatment. From the women who 
were ultimately diagnosed as having atrophy, 21 of 23 would have been directly referred to 
the regular screening program. The remaining seven women would have been referred 
directly to the gynecologist, because of the high probability (greater than 99.9%) that these 
subjects have high-grade CIN. 
Table 1. Mean PAI values in MIB1 restained Pap smears before and after estrogen 
therapy. 
Diagnosis 
Atrophy 
CIN2 
CIN3 
Ν 
23 
3 
4 
PAIbefore 
mean ± SD 
0.05 ± 0.04 
0.35 + 0.05 
0.48 ± 0.02 
PAUfter 
mean ± SD 
0.01 ± 0.02 
0.34 ± 0.04 
0.47 + 0.03 
p-value 
< 0.001 
0.4 
0.2 
The p-values in the table were obtained from the Wilcoxon signed-rank test for paired 
observations. 
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Figure 3. PAI values of the 30 women before estrogen therapy. The threshold values of the 
two classifiers for discriminating between cervical atrophy and high-grade CIN (PAI = 0.17), 
and for subdividing high-grade CIN into CIN2 or CIN3 (PAI = 0.41) are represented by the 
dashed lines. The two threshold values (PAI = 0.70 and PAI = 0.25) of the diagnostic 
decision tree are given as unbroken lines. 
The effects of estrogen administration on the proliferative activity in cervical atrophy and 
high-grade CIN are given in table 1. This table discloses that the mean PAI values of cases 
with high-grade CIN did not change due to estrogen therapy. The mean PAI values of the 
cases with cervical atrophy exhibited significant changes due to estrogen treatment. Figure 4 
gives the proportional change of the PAI values due to estrogen treatment of each case. 
More than ninety percent of cases with cervical atrophy showed a reduction in PAI values> 
50% after hormone treatment. 
Discussion 
We suggested recently that measuring PA! in MIB1 restained smears might be a reliable and 
safe procedure for limiting additional diagnostic procedures for postmenopausal women with 
atypical cervical atrophy, and for preventing a doctor's delay in treatment of women with 
high-grade CIN lesions (12). Application in the present study of the diagnostic decision tree, 
as proposed in the latter study, would have resulted in a reduction of 93% of estrogen 
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courses and subsequent Pap smears This corresponds well with the estimated 90% 
reduction rate, as based on previous statistical considerations (12) According to the 
diagnostic decision tree, all seven cases ultimately diagnosed as high-grade CIN would have 
been referred correctly without any delay, to the gynecologist for further treatment This is in 
agreement with the low predicted occurrence of a serious decision error, defined as a false-
negative diagnosis of high-grade CIN, in less than 1 of 1000 postmenopausal women with an 
atypical Pap smear 
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Figure 4. Proportional change of PAI values after estrogen treatment. The proportional 
change is defined as (PAUer- PAIbefore) / PAIbetore χ 100 %. The dashed lines represent the 
0% and 50% reduction levels of PAI 
In contrast to mature cervical epithelium, in histological sections cervical atrophy is 
characterized by a decreased number of proliferating cells and the presence of proliferating 
cells at higher levels within the epithelium Due to the presence of proliferating cells in the 
more superficial layers of the epithelium, the PAI values in cervical atrophy are greater than 
in normal mature cervical epithelium (12) The mean PAI value after hormone treatment was 
the same as that previously reported for a control group of premenopausal women (0.01 + 
0.02) (12). These findings support the earlier findings that the cell cycle of normal cervical 
epithelium is hormonally regulated under physiological conditions. The proliferative activity in 
normal cervical epithelium is negatively correlated with the number of estrogen receptor (ER) 
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expressing cells and positively correlated with the number of progesteron receptor (PR) 
expressing cells High-grade CIN lesions, especially those infected with the oncogenic 
human papillomavirus (HPV) subtypes 16/18, were reported to be ER negative and PR 
positive (13) In a more recent study, it was shown that malignant transformation of CIN 
lesions is associated not only with reduced ER and increased PR expression, but also with 
elevated expression of cyclms, cyclin-dependent kinases and p53 (14) The latter study gave 
evidence that malignant transformation of cervical epithelium is associated with both loss of 
normal growth control by steroid hormones and by aberrant expression of cell cycle 
regulatory proteins Our findings of unchanged proliferative activity after estrogen therapy in 
high-grade CIN lesions provide further evidence that dysplastic epithelium escapes normal 
cell cycle regulating mechanisms The finding of unchanged PAI values in high-grade CIN is 
also in agreement with the observations that the cytomorphological aspects of dysplastic 
epithelium do not change under estrogen influence (7). 
Finally, although cost-effectiveness analyses were not performed, there is strong reason to 
expect that MIB1 restaming of non-conclusive Pap smears will result in decreased costs of 
the cervical cancer screening programs The extra costs for immunocytochemical 
examination of the Pap smear will be small, compared to the money saved by preventing the 
hormone treatment and subsequent visits to and cervical smears taken by the general 
practioner or gynecologist and the evaluation of this smear by the pathologist. In our series of 
23 postmenopausal women with cervical atrophy, 53 additional Pap smears were made 
within a follow-up period of 5 years, including those performed just after estrogen course 
Applying the diagnostic decision tree to the same series, only two additional Pap smears 
would have been needed in the same period. 
We conclude that the measurement of PAI in MIB1 restained Pap smears is a simple, rapid, 
reliable, safe, and probably also a cost-effective method to obtain a considerable reduction of 
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additional diagnostic procedures in postmenopausal women with an atypical Pap smear, 
based on well-established cell biological mechanisms. 
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ABSTRACT 
The aim of this study was to detect numerical chromosomal aberrations that may be involved 
in the progression of cervical intraepithelial neoplasia (CIN) towards cervical carcinoma 
Therefore, cervical lesions (5xCIN1, 7xCIN2, 6xCIN3, 6x invasive carcinomas, 6x normal) 
were studied by in situ hybridization (ISH) on serial 3-μιη thick paraffin tissue sections, using 
a panel of eight centromeric DNA probes for chromosomes 1, 3, 6, 7, 8, 11, 17, and X An 
estimation of the percentage of dysplastic epithelium with abnormal ISH signals per nucleus 
was made. Chromosome aneusomy could be detected in all persisting and high-grade CIN 
lesions and invasive carcinomas In most cases, when one of the chromosomes showed 
aneusomy then all studied chromosomes showed numerical changes. Interestingly, the 
abnormal ISH signals were found only in a varying part of the morphologically dysplastic 
epithelium, the remainder showing no such changes. In aneuploid regions of the CIN 1 
lesions the mean chromosome index (CI) for all chromosomes was 1 97 ± 0.03 with a range 
of 1.92 - 2 00 The CI ratios of chromosomes 1, 7 and X showed a significant positive 
correlation with CIN grade (r>0.74, p<0.006). 
It is concluded that chromosome aneusomy of chromosomes 1, 7 and X may be involved in 
the progression of CIN lesions 
INTRODUCTION 
Squamous cell carcinoma of the uterine cervix is one of the most frequent cancers among 
women. In most of the developed countries, governments have set up screening programs to 
detect and to treat premalignant cervical intraepithelial neoplasia (CIN) before progression to 
life-threatening invasive carcinomas. These screening programs have resulted in a 
considerable reduction of the incidence of cervical cancer and in a reduction of the mortality 
rate of this disease (1,2). However, even in well controlled screening programs, 
overtreatment of a considerable number of nonprogressive CIN lesions is the price that has 
to be paid for this reduction. This is due to the inability to discriminate between progressive 
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and regressive CIN lesions on the basis of cytomorphological features The reported 
progression rates of CIN 1 lesions as diagnosed in cervical smears into higher grades of CIN 
vary from approximately 10 to 50% (3) The overall progression rate of CIN to cervical cancer 
is probably much lower The relative risk of developing cervical cancer appeared to be 
dependent on the grade of the CIN lesion (4,5) 
Infection with oncogenic human papilloma viruses (HPV) is considered to be the most 
important etiologic factor in carcinogenesis of cervical cancer (6-9) The integration sites of 
viral DNA seem to be located near fragile sites, proto-oncogenes and chromosomal 
breakpoints (10,11) Hyperproliferation and genetic instability are considered to be the results 
of mactivation of pRb and p53 by the viral E7 and E6 oncoproteins respectively (12-16) In 
cervical cancer, structural rearrangements of chromosome 1 have been described to be the 
most frequent karyotypic changes, more than 90% of the patients showed rearrangements of 
this chromosome (17) Several structural aberrations, such as deletions, translocations of 
parts of chromosome 1 onto other chromosomes, isochromosomes, and inversions, have 
been described (17-19) Chromosomal aberrations have also been reported for 
chromosomes 3, 6, 11 and 17 (19-22) Trisomy and polysomy were found for all 
chromosomes (18,19) In an ISH study of cervical smears of a random sample of CIN 
lesions, a gradual increase of the incidence of numerical aberrations of chromosome 1 was 
observed with increasing CIN grade (23) Sofar, such data are not available for other 
chromosomes 
Especially, in premalignant lesions the preservation of histological architecture is important in 
the study of genetic changes These lesions are frequently very small, and a proper 
diagnosis is not possible in disaggregated cells, as the resulting loss of morphology prevents 
the correlation between the histological features and chromosomal aberrations Therefore, 
interphase cytogenetics on formalin-fixed and paraffin-embedded tissue sections is needed 
to study the occurrence of numerical chromosomal aberrations in premalignant epithelial 
tissue (24,25) 
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In this retrospective study, centromere specific probes were used in ISH procedures 
performed on 3- to 4-pm cervical tissue sections of patients who were surgically treated for 
persistent or high-grade CIN lesions, or for an invasive carcinoma of the uterine cervix and of 
control subjects without evidence of CIN The aims of this study were 1) to assess 
chromosome aneusomy for chromosomes 1, 3, 6, 7, 8, 11, 17 and X in CIN lesions and 
invasive carcinomas, 2) to determine whether chromosome aneusomy is homogeneously or 
heterogenoeusly distributed throughout the dysplastic epithelium of these lesions and 3) to 
assess whether aneusomy of these chromosomes is correlated to the grade of the CIN 
lesions. 
MATERIALS AND METHODS 
Patients 
Paraffin blocks from 6 cases of normal cervix, 19 cases of CIN and 5 cases of invasive 
carcinoma of the cervix uteri were used. The cervical biopsies and invasive carcinomas were 
independently graded by two pathologists CIN 1, 2, and 3 were classified according to the 
generally accepted criteria (26). In CIN 1, the cellular abnormalities as minimal nuclear 
anomalies, mild hyperchromasia, mitotic figures and dyspolanty are restricted to the basal 
and parabasal parts of the epithelium In CIN 2, these abnormalities are moderate and 
present in the lower two-thirds of the epithelium CIN 3 shows dyspolanty and mitotic activity 
in all layers of the epithelium. Nuclear atypias are severe and abundant In case of 
discrepancy, the final grade of CIN was obtained by consensus with a third pathologist. The 
grading results were as follows 5 cases with CIN 1, 7 cases of CIN 2, and 7 cases of CIN 3. 
The mean ages of the patient groups with CIN 1, 2, and 3 and invasive carcinomas were 42 
± 7, 37 ± 6, 34 ± 3 and 47 ± 22 years, respectively. 
The mean age of the control group was 42±14 years (Table 1) Nine of 11 (82%) patients 
with CIN 1 or CIN 2 had successively two or three abnormal Pap smears before the biopsy 
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1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
36 
29 
50 
66 
39 
32 
42 
45 
45 
30 
48 
44 
29 
Normal 
Normal 
Normal 
Normal 
Normal 
Normal 
CIN1 
CINI 
CINI 
CINI 
CINI 
CIN2 
CIN2 
Table 1. Clinico-pathological data and DNA-ISH results with calculated percentages 
of morphologically abnormal epithelium with abnormal signal countings (>2 
ISH signals per nucleus) for chromosomes 1, 3, 6, 7, 8,11,17, and X. 
Case Age Histological History Chromosome Fractional 
No (years) Diagnosis Aneuploidy Area 
Uterus prolaps 
Uterus prolaps 
Uterus prolaps 
Uterus prolaps 
Uterus myomatosus 
Uterus myomatosus 
3 smears (CINI, 7 5 years)1 + 100 
3 smears (CIN1,27 months) + 25 
6 months after ablatio CIN1 in re-ablatio 
3 smears (CIN1 1 year) +* 100 
14 months after ablatio CIN1 in re-ablatio 
2 smears (CINI, 6 months) + 15 
1 smear (CIN1, 6 months) 
2 smears (CIN2 1 month) +"* 60 
3 smears (CINI 7 months) +" 65 
6 months after ablatio CIN3 in re-ablatio 
14 34 CIN2 2 smears (CIN1,2 months) + 10 
23 months after ablatio CIN3 m re-ablatio 
15 45 CIN2 3 smears (CIN1,CIN2,9 months) +'* 70 
3 months after ablatio CIN3 in smear 
16 38 CIN2 3 smears (CIN1,4 months) + 80 
17 39 CIN2 4 months after ablatio CIN3 in smear + 10 
No complete clinical data 
18 29 CIN2 1 smear (CIN 1 2 months) + 15 
19 31 CIN3 1 smear and 2 biopsies (CIN3,5 months) + 35 
3 and 7 months after ablatio CIN1 in smear 
20 41 CIN3 2 smears and 2 biopsies (CIN3,7months) +* 100 
18 months after ablatio CIN3 in re-ablatio 
21 31 CIN3 1 smear (CIN3 1 month) + 152 
100 
22 34 CIN3 1 smear (CIN3, 1 month) + 10 
3 and 6 months after ablatio CIN1 in smears 
23 34 CIN3 1 smear (CIN3 1 month) + 40 
24 34 CIN3 1 smear (CIN1 6 years) 2 smears (CIN3, 5 + 80 
monlhs) 
25 32 CIN3 1 smear (CIN3, 1 month) + 15 
18 months after ablatio CIN3 in re-ablatio 
26 23 SCC 1 smear (CIN3 1 month) +'* 100 
1 biopsy (SCC) 
1 smear (SCC) + 100 
1 smear (suspicious for SCC, 1991) + 100 
10 months after uterus resection SCC in 
vagina-top 
1 smear (SCC) + 100 
1 smear (SCC) +^  100 
Fractional area is the percentage of the length of a region of abnormal epithelium with abnormal signal countings 
(more than two ISH signals per nucleus) 
The number of previous abnormal smears and the time interval between the first abnormal smear and the 
biopsy 
2
 chromosomes 1 and 3 showed aneusomy diffusely in the whole CIN3 lesion, the other chromosomes 
exhibited aneuploidy only focally 
Chromosome 3 not évaluable 
" Chromosome 11 not évaluable 
Chromosome 8 not évaluable 
" Chromosome 17 not évaluable 
27 
28 
29 
30 
72 
37 
35 
68 
SCC 
SCC 
SCC 
SCC 
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was taken (Table 1) One of the patients with a CIN 2 lesion was excluded due to incomplete 
clinical data In 5 of 11 (45%) patients with an initially diagnosed CIN 1 or CIN 2 lesion 
(cases no 8, 9, 13, 14 and 15), the lesions persisted or progressed into a higher grade of CIN 
according to Pap smear or cervical biopsy during follow-up, despite the removal of a 
considerable part of the cervical mucosa during the first ablatio 
DNA probes for ISH 
The centromere-associated DNA probes pUC 1 77 (27), pa3.5 (28), p308 (29), p7t130 (30), 
D8Z2 (31), pLC11A(32), p17H8(33), and pBAMXS (34) were used for the detection of target 
sequences on chromosomes 1, 3, 6, 7, 8, 11, 17, and X. The probes were labeled by nick-
translation with biotin-14-dATP, according to the supplier's instructions (BRL, Gaithersburg, 
MD) 
In Situ Hybridization 
The choice of a section thickness of 3 pm was based on the results of a pilot study on CIN 
lesions The 3-ym tissue sections were processed and pretreated as described previously 
(35) Briefly, the samples were incubated in 1M NaSCN (Merck, Darmstadt, Germany, 10 
mm, 80oC), followed by rinsing in sterile water (MQ). To obtain a good penetration for DNA 
probes and antibodies into the nuclei, the cells were permeabilized with 4 mg (8000 U) 
pepsin from porcine stomach mucosa (Sigma; St.Louis, MO, USA) per ml of 0.2 M HCl in a 
time series from 5 to 30 mm at 37C,C. Next, the slides were rinsed in MQ, dehydrated and air-
dried. The DNA probes were hybridized to the tissue sections at a probe concentration of 2 
ng/μΙ hybridization mixture, containing 60% formamide (Merck), 2x standard sodium citrate 
(SSC), 10% dextransulfate (Sigma) and 50 ng/μΙ herring sperm DNA (Boehrmger, 
Mannheim, Germany), pH 7.0 Fifteen μΙ of the hybridization mixture was applied to the 
slides under a coverslip (14 χ 32 mm) Denaturation of probe and target DNA was performed 
simultaneously by heating the slides in a moist chamber to 80oC for 10 mm After 
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hybridization for 16 hours at 370C1 the covershps were removed by immersing the slides in 
2xSSC, pH 7 0 at 420C. Posthybridization washing steps were performed twice in 60% 
formamide, 2xSSC, pH 7.0 for 5 mm and twice in 2xSSC, pH 7 0 for 5 mm at 420C Next, the 
slides were rinsed in PBS/0 05% Tween 20 (PBST, Merck) Demonstration of the biotmylated 
DNA probes was performed by the standard avidin-biotin complex (ABC) procedure. A 
CARD-ISH signal amplification procedure (36) was performed for DNA probes of 
chromosomes 3 and 11, for these probes, the standard ISH method gave rather weak 
signals Therefore, the samples were incubated with biotm-tyramme solution (0 07 μΜ) and 
0 01% H2O2 for 2 min at room temperature The biotin precipitate was detected with a second 
incubation of ABC for 20 min at 370C Visualization of the probe label was accomplished by 
precipitating diaminobenzidme (Sigma) through the reaction of HRP and H2O2 The DAB 
signal was intensified with 0.5% CUSO4 in 0.9% NaCI. Sections were counterstained with 
Mayer's haematoxylin 
Evaluation of ISH Results 
Only slides with morphologically well demarcated, non-overlapping, and well preserved 
nuclei with separated ISH signals were evaluated as reported earlier (35,37). Regions of the 
epithelium were considered to have chromosome aneusomy when multiple nuclei with more 
than two ISH signals per nucleus were present Within dysplastic epithelium, regions with 
and without chromosome aneusomy were demarcated. Subsequently, the lengths of the 
selected regions, parallel to the mucosal surface, were measured From these data the 
percentages of the lengths of the regions (Fractional area) with chromosome aneusomy were 
estimated. This was done for each chromosome of all abnormal cases In 22 of our 30 
specimens (6 normal, 4 CIN 1, 4 CIN 2, 4 CIN 3, and 4 carcinomas), the ISH results could be 
quantified for at least 6 of the 8 chromosomes of our panel In the remaining 8 cases, only a 
subjective examination was possible, because the quality of the ISH signals did not allow a 
reliable signal counting. For each chromosome, the number of ISH signals per nucleus were 
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counted in up to 200 nonoverlappmg nuclei in control subjects, in normal epithelium adjacent 
to CIN lesions, in CIN lesions, and in carcinomas. Within CIN lesions, regions with and 
without chromosome aneusomy were identified and separately counted The chromosome 
index (CI) was calculated for each investigated chromosome. The CI is defined as the mean 
number of chromosome copies per nucleus in the sample of measured nuclei When CI is 
measured in a sample of nontruncated diploid cells the CI will approach the theoretical value 
of 2. The CI of diploid cells measured in truncated nuclei in tissue sections is always smaller 
than 2, and its value is mainly dependent on the ratio of the nuclear volume and tissue 
section thickness, the spatial distribution of the centromeres in the interphase nucleus, and 
the true number of chromosomes in the nonsectioned nucleus (38). If the centromeres of the 
different chromosomes have a comparable spatial distribution and the section thickness is 
constant, then the mean CI measured in a sample of diploid cells will be almost equal for the 
different chromosomes. In this study, an aberrant CI was defined as any value of CI greater 
than the mean value of CI plus 2 58xSD obtained from normal epithelium of the uterine 
cervix in a control group. By this definition, fewer than one case per 500 women without CIN 
lesions exceeded this treshold. Variations in hybridization conditions and section thickness 
between the individual cases may influence the CI values, due to lack of internal control 
Therefore, for each chromosome the CI ratio, defined as the ratio of the CI value of the 
regions with chromosome aneusomy and the CI value of normal epithelium adjacent to the 
CIN lesion, was calculated 
Statistics 
The correlation between the grade of the CIN lesion and CI and CI ratios were assessed by 
Spearman's rank correlation coefficient (r) Differences in CI and CI ratios between two 
groups were analyzed by Student f test for unpaired observations, and differences between 
more than two groups were assessed by a one-way analysis of variance (ANOVA). When 
significant differences between groups were found by the one-way ANOVA a modified least 
significant difference (LSD) test according to Bonferroni with a significance level of 0 05 was 
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used to elucidate which groups are mutually different All statistical analyses were performed 
with SPSS for Windows 
RESULTS 
The patient history the classification of the cervical lesions and the ISH results are 
summarized in Table 1 
Normal cervical epithelium of the six control cases and all morphologically normal areas 
adjacent to the CIN lesions did not show chromosome aneusomy for any of the investigated 
chromosomes Figure 1a illustrates the ISH results using a DNA probe for chromosome 1 in 
normal cervical epithelium The H&E-stamed section of the same region is given in Figure 
1b All SCC demonstrated chromosome aneusomy of all investigated chromosomes 
throughout the tumor The ISH results of 18 of 19 CIN cases (94%) showed chromosome 
aneusomy of all investigated chromosomes If chromosome aneusomy was found in a 
demarcated region for one chromosome then all investigated chromosomes demonstrated 
chromosome aneusomy in the same region of the epithelium The hybridization results 
revealing chromosome aneusomy for chromosomes 1, 6, and 7 of a CIN 1 lesion, are 
demonstrated in Figure 1c to e Figure 1f demonstrates the same region in a H&E-stamed 
section 
Regarding the distribution of the chromosome aneusomy within the morphological abnormal 
epithelium, we found that in many CIN lesions chromosome aneusomy was only focally 
present Figure 2, a and b illustrates this for a CIN3 lesion The corresponding areas in H&E-
stamed sections are shown in Figure 2, c and d, respectively The fractional areas of 
abnormal epithelium with aberrant chromosome copies are given in the last column of Table 
1 The fractional areas ranged from 10 to 80 % in 14 of 18 CIN lesions Three of the 
remaining four CIN lesions (cases no 7, 9 and 20) showed diffusely chromosome aneusomy 
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Figure 1. Interphase cytogenetic analysis on 3-pm paraffin sections using biotinylated 
probes specific for chromosomes 1, 6 and 7, counterstained with Mayer's haematoxylln. A: 
The normal cervical epithelium shows not more than two ISH signals per nucleus for 
chromosome 1. B: The H&E-stained section with the same region. C to E: The dysplastic 
epithelium of a CIN 1 lesion shows three or four copies per nucleus for chromosomes 1, 6, 
and 7 in the same area, respectively. F: The H&E-stained section with the same CIN 1 
region. Magnification, x400. 
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Figure 2. Interphase cytogenetic analysis using a biotinylated probe for chromosome 17 on 
3-pm paraffin sections counterstained with Mayer's haematoxylin. In the case of a CIN 3 
lesion with focally chromosome aneusomy. the dysplastic epithelium shows three or more 
copies per nucleus (A), whereas the same CIN 3 lesion shows not more than two copies per 
nucleus in another area (B). C and D: The corresponding areas in the H&E-stalned sections, 
respectively. Magnification, x400. 
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One CIN lesion (case no 21) demonstrated diffusely aneusomy for chromosomes 1 and 3, 
whereas there was focal aneusomy for all other investigated chromosomes. One CIN lesion 
(case 11) did not show chromosome aneusomy 
The mean values of the CI values of the 8 chromosomes were comparable in normal 
epithelium of the control group and in the normal epithelium adjacent to the CIN lesions and 
varied between 1 17 and 1.21 (Table 2). In normal cervical epithelium, the CI was, due to 
nuclear truncation, reduced with a factor 1 7 from 2.0 to 1.19. Using the mean value plus 
2.58 χ SD, a CI > 1 4 is highly suggestive for gam of chromosomes The variations in CI 
values between the control subjects were small for all chromosomes (Figure 3) 
Table 2. Chromosome indices (CI) of the 8 chromosomes in normal epithelium of the 
controls and the regions with chromosome aneusomy of dysplastic 
epithelium in CIN1, CIN2, and CIN3, and in invasive squamous cell 
carcinomas. 
Chromo­
somes 
1 
3 
6 
7 
8 
11 
17 
X 
All 
normal 
(N=6) 
1 21 ± 0 08 
1 17 ± 0 07 
1 17 ± 0 09 
1 20 ± 0 08 
1 21 ± 0 09 
1 18 ± 0 07 
1 19 ± 0 06 
1 18 ± 0 06 
1 1 9 ± 0 0 1 
Chromosome indices (mean + SD) 
CIN1 
(N=4) 
1 97 ± 0 14 
1 96 ± 0 04 
1 98 ± 0 10 
1 92 ± 0 15 
1 97 ± 0 13 
1.98±018 
2 00 ± 0 14 
1 94 ± 0 19 
1 97 ± 0 03 
CIN2 
(N=4) 
2 1 7 ± 0 1 4 
2 24 ± 0 09 
2 1 3 ± 0 1 0 
2 23 ± 0 30 
2 09 ± 0 10 
1 90 ± η a 
2 0 4 1 0 1 8 
2 29 ± 0 21 
2 1 4 ± 0 1 3 
CIN3 
(N=4) 
2 28 ± 0 35 
2 18 ± 0 27 
1 99 ± 0 08 
2.35 ± 0.34 
2 07 ± 0 17 
2 02 ±0 24 
1 97 ± 0 10 
2 50 ± 0 31 
2 1 7 ± 0 1 9 
Invasive 
carcinoma 
(N=4) 
2 2 3 ± 0 1 9 
1.90 ± 0 24 
2.05 ± 0 23 
2 00 ± 0 33 
2 08 ± 0.22 
1.88 ± 0 30 
2 05 ± 0 16 
2 30 ± 0 39* 
2 06 ± 0 15 
r 
0.44 
0 43 
0 03 
0 71 
0 48 
-0.04 
-0 15 
0 74 
Ρ 
0 149 
0 251 
0 927 
0 010 
0 137 
0.907 
0 964 
0 006 
r Spearman's rank correlation coefficient for correlation between CI and grade of CIN lesion. 
Ρ significance level of correlation 
*• sigmfacant different from CIN1 at a signicance level of 0.05 in LSD test. 
In the CIN1 lesions, the mean CI values in areas with chromosome aneusomy had 
comparable values for all investigated chromosomes varying from 1 92 to 2 00 with an 
overall mean CI of 1 97 pooled over all chromosomes (Table 2 and Figure 3). The 
differences between the mean CI of the control group and the mean CI of the areas with 
chromosome aneusomy in the 4 CIN 1 cases were statistically significant for all 
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chromosomes (p<0.003), and for all individual CIN 1 patients the mean CI exceeded the 
threshold value of 1.4 for all chromosomes. In the CIN1 lesions, the mean CI pooled over all 
chromosomes was 1.65 times greater than the mean CI of normal epithelium of the control 
N= 64444 63243 64444 64444 64434 64143 64443 64444 
#1 #3 #6 #7 #8 #11 #17 #X 
Figure 3. The mean chromosome indices (CI) and their standard error of means (bars) of 
CIN lesions, invasive carcinomas and normal cervical epithelium. N, the number of cases In 
each of the categories; # indicates chromosome number. 
There was more diversity in the CI values in the areas with chromosome aneusomy of the 
CIN 2 and CIN 3 lesions than in the CIN 1 lesions, and the mean CI values of chromosomes 
1, 3, 7, and X are higher in CIN 2 and 3 lesions than in CIN 1 lesions (Table 2 and Figure 3). 
The chromosomes 7 and X showed a significant positive correlation between the mean CI 
and the CIN grade (r>0.71, p<0.01;Table 2). The standard errors of means of CI values are 
large due to the inter-patient variations and small series of patients in the different groups of 
CIN patients (Figure 3). Therefore, the one-way ANOVA disclosed significant differences 
only between the three grades of CIN lesions for chromosome X (p=0.02). LSD test 
disclosed a significant difference at a significance level of 0.05 for only the mean CI values 
for chromosome X between CIN 1 and CIN 3. For chromosomes 3, 7 and X the mean CI 
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values m the invasive carcinomas were obviously smaller than in the group of CIN3 lesions 
(Figure 3), although the differences were not significant (p>0 2) The CI values of the 
dysplastic regions without chromosome aneusomy were in the same range as the CI values 
of normal epithelium from the control subjects (data not shown) 
In Table 3, the CI ratios are given The CI ratios for chromosomes 1, 7, and X showed a 
significant positive correlation between the mean CI and the CIN grade (r>0 74, p<0.006). 
ANOVA disclosed significant differences between the three grades of CIN lesions for 
chromosomes 1 and X (p=0 03 and 0 01, respectively). The LSD test disclosed significant 
differences at a significance level of 0 05 for the mean CI ratios for chromosomes 1 and X 
between CIN 1 and CIN 3 (Table 3) 
Table 3. CI ratios of the 8 chromosomes in the regions with chromosome 
aneusomy of dysplastic eptihelium in CIN1, CIN2, CIN3, and invasive 
squamous cell carcinomas. 
CI ratio (mean + SD) 
chromo­
somes 
1 
3 
6 
7 
8 
11 
17 
X 
All 
CIN1 
(N=4) 
1 69 ± 0 12 
1 77 ± 0 06 
1.75 ±0.13 
1.68 ±0.10 
1 70 ± 0 13 
1.75 ±0.21 
1 74 ±0.10 
1 71 ±0.10 
1 72 ± 0.03 
CIN2 
(N=4) 
1.88±016 
1 . 8 6 ± 0 1 0 
1.80 ± 0 07 
1 93 ± 0 32 
1 78 ± 0 13 
1.60" 
1.78 ±0.26 
1.95 ± 0 14 
1.82±0.11 
CIN3 
(N=4) 
2 06 ± 0.20' 
1 87 ± 0.28 
1.77 ±0.13 
2 05 ± 0 27 
1 92 + 0 21 
1 79 ± 0 29 
1 74 ± 0 13 
2 19 ± 0 25* 
1 92 ± 0 16 
Invasive 
carcinoma 
(N=4) 
1 98 ± 0 20 
1 69 ±0.21 
1 76 ±0.18 
1 79 ± 0 27 
1 83 ± 0 19 
1 67 ± 0.27 
1.80 ±0.21 
2 00 ± 0.30 
1 82 ± 0 12 
r 
0 74 
0 04 
0.03 
0 80 
0 43 
-0 09 
0 00 
0 83 
Ρ 
0 006 
0 909 
0.927 
0.002 
0 183 
0 815 
1.000 
0 001 
r Spearman's rank correlation coefficient for correlation between CI ratio and grade of CIN 
lesion 
P" significance level of correlation 
SD not evailable. 
* significant different from CIN1 at a significance level of 0 05 in LSD test. 
Discussion 
This retrospective case control ISH study on tissue sections of persistent and high-grade CIN 
lesions and invasive sqaumous cell carcinomas showed that chromosome aneusomy was 
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present for chromosomes 1, 3, 6, 7, 8, 11, 17, and X in all invasive carcinomas in all CIN 2 
and CIN 3 lesions, and in 4 of the 5 cases of CIN 1 lesions In the invasive carcinomas 
chromosome aneusomy was found diffusely throughout the tumor Of special interest, and 
not reported earlier, was our observation that in the majority of CIN lesions chromosome 
aneusomy occured only focally within the dysplastic epithelium The fractional area of 
dysplastic epithelium with chromosome aneusomy varied from 10 to 80%, and these 
percentages were not related to the grade of the CIN lesion In only 3 of 19 CIN lesions was 
chromosome aeusomy diffusely present in the dysplastic epithelium 
In the CIN 1 lesions with chromosome aneusomy, the mean CI values for the chromosomes 
1, 3, 6, 7, 8, 11, 17, and X did not differ significantly and had a mean value of 1 97 ± 0 03 for 
all chromosomes with a range of 1 92-2 00 This observation suggested that the numerical 
chromosome aberrations are the result of polyploidization, because the CI values were in the 
same range for these chromosomes This observation is in agreement with the results of an 
image cytometric DNA study on progressive CIN lesions in which it was shown that 80% of 
CIN 1 lesions had a polyploid DNA histogram (39) In the CIN 2 and CIN 3 lesions there were 
significant differences in the CI values for the different chromosomes examined in the 
present study Despite the small series of patients in each of the CIN categories, we found 
statistically significant positive correlations between CI and the CIN grade for chromosomes 
7 and X Using the CI ratios, a significant correlation with the CIN grade was found for 
chromosomes 1, 7, and X For chromosomes 1, 3, 6, 8, 11, and 17 no correlation between CI 
and CIN grade was observed, nor were significant differences seen in CI values between the 
different CIN lesions These observations suggested that not all chromosomes are involved 
in the same manner during progression to higher CIN grades In addition, the numerical 
chromosome aberrations for the different chromosomes in CIN 2 and CIN 3 lesions may also 
be an explanation for the high prevelance of aneuploid DNA histograms in progressive CIN 2 
and 3 lesions (39,40) In the former study, DNA aneuploidy was found in 60 and 74% of 
progressive CIN 2 and CIN 3 lesions, respectively The discrepancies in the prevalence of 
DNA aneuploidy in progressive CIN 2 and 3 lesions and the prevalence of chromosome 
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aneuploidy detected by ISH in such lesions may be caused by the focal presence of 
numerical chromosome aberrations in CIN lesions In our series of CIN 2 and 3 lesions, in 
43% of the cases < 15% of the dysplastic epithelium exhibited chromosome aneusomy 
In a prospective ISH study with centromere-specific probe for chromosome 1 in cervical 
smears of nonselected patients with CIN lesions it was shown that aberrant CI values were 
only found in higher-grade CIN lesions (23). In the groups of CIN 2 and CIN 3 lesions the 
prevalences of an aberrant CI of chromosome 1 were 18% and 53%, respectively This 
progressive increase of the prevalence of aberrant CI for chromosome 1 with increasing CIN 
grade is very interesting, because it is well known from the literature that the relative risk of 
developing a squamous cell carcinoma of the uterine cervix also increases with the increase 
of the CIN grade (3-5) These observations in a nonselected group of patients with CIN 
lesions, and our findings in a selected series of high-grade and/or progressive CIN lesions, 
suggest that numerical chromosome aberrations may be associated with progression It 
seems likely that aneuploidization is mainly the result of gain of some preferential 
chromosomes. Our ISH study with centromere-associated DNA probes did not give any 
information about loss and/or gain of chromosome regions possibly associated with tumor 
progression However, it is likely that progression to high-grade CIN and invasive carcinomas 
is also accompanied by structural chromosome aberrations Deletions on the short arm of 
chromosome 3 at 3p25 and 3p14 seem to be early events in the development of carcinoma 
of the cervix (41) More recently, it was assumed that gain of chromosome 3q in aneuploid 
cells represents a pivotal genetic aberration at the transsition from severe dysplasia/ 
carcinoma in situ to invasive cervical cancer (42) All these findings suggest that tumor 
progression is associated with numerical and/or structural aberrations of a selected series of 
chromosomes 
As all cervical carcinomas in our study exhibited diffuse chromosome aneusomy, it looks 
likely that they develop from CIN regions with focal chromosome aneusomy. The detection of 
chromosome aneusomy seems to be a more appropriate feature to predict the biological 
behaviour of non-invasive cervical lesions than the morphological features. 
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In conclusion we assume that CIN lesions with chromosome aneusomy may predispose to 
the progression into higher-grade CIN lesions and invasive carcinomas, whereas CIN lesions 
without numerical chromosome aberrations may be associated with a regressive behaviour 
Validation of these assumptions in a large prospective study of cytological cervical samples 
of patients with a long follow-up period is of great clinical relevance 
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Summary 
The aim of this study was to describe a method for amplifying human papilloma virus (HPV) 
in situ hybridisation (ISH) signals. 
Therefore, three human cervical cell lines, namely CaSKi, HeLa and SiHa, containing 
different copy numbers of integrated HPV DNA were studied. Following ISH, catalysed 
reporter deposition (CARD), based on the deposition of biotinylated tyramine at the location 
of the DNA probe, was used to amplify the ISH signal. 
Using CARD-ISH, one to three HPV type 16 copies were detected in situ both in cell 
suspensions and paraffin wax sections of SiHa cells. CARD-ISH can also be used to detect 
oncogenic HPV DNA sequences, such as HPV types 16 and 18, in routinely processed 
formalin fixed, paraffin wax embedded cervical specimens. 
In conclusion, CARD-ISH is a fast and highly sensitive ISH method for the routine detection 
of low copy number HPV DNA sequences in cervical cell lines and routinely processed tissue 
sections. Application of this technology also enables the routine detection and cellular 
localisation of other viral DNA sequences present at copy numbers below the detection limit 
of conventional ISH methods 
Key words: In situ hybridisation, signal amplification, cell lines, human papilloma virus, 
cervix uteri 
Introduction 
Recently, we described a novel ISH signal amplification method, using catalysed reporter 
deposition (CARD-ISH) (1) This amplification method is based on the deposition of 
biotinylated tyramine by the activity of horseradish peroxidase (HRP) at the location of the 
DNA probe. The procedure was introduced initially for immunoassays and 
immunohistochemistry (2-4) In our method, the biotinylated tyramine precipitate can be 
visualised within cells using fluorochrome or enzyme labelled avidm The detection limit is 
102 
increased substantially for both bnghtfield and fluorescence ISH The CARD-ISH signal 
amplification technique is particularly suitable for the visualisation of low copy number DNA 
sequences, but may also be valuable for the detection of (oncogenic) viruses The CARD-
ISH procedure is rapid, flexible, and easy to implement in standard ISH protocols (1,5) 
Infection with certain human papilloma virus (HPV) types, especially types 16 and 18, has 
been postulated to be a high risk factor for the development of human squamous cell 
carcinoma of the uterine cervix (6-9). Using PCR, viral infection can be detected rapidly even 
if only a few cells in a given tissue or cytological sample contain the DNA sequence of 
interest (10). However, one of the major disadvantages of PCR analysis is that there is no 
direct correlation with morphology (11).The application of ISH techniques for the detection of 
HPV sequences is preferred in order to correlate the presence of HPV DNA with 
morphological aspects of the cells or tissue. However, the value of conventional ISH 
techniques is limited by its detection sensitivity of about 20 copies per cell (10) Nuovo et al 
(12,13) have developed a PCR-ISH technique that combines the extreme sensitivity of PCR 
amplification and morphological preservation of ISH, and have applied this technique to cell 
lines (12) and formalin fixed, paraffin wax embedded sections (13) for the detection of HPV 
DNA Disadvantages of this procedure are that it can lead to false positive results because of 
non-specific PCR reactions and that it is laborious and therefore is not always available 
routinely In an attempt to overcome these disadvantages, we adapted the CARD-ISH 
method for use on formalin fixed, paraffin wax embedded cervical sections 
Methods 
Cell and tissue samples 
The human cervical carcinoma cell lines CaSki (ATCC; CRL1550), containing about 500 
integrated copies of HPV 16 DNA, HeLa (ATCC; CCL2), containing about 20-50 integrated 
copies of HPV 18 DNA, and SiHa (ATCC; HTB35), containing one to three integrated copies of 
HPV 16 DNA, were used to determine the sensitivity and specificity of the CARD-ISH method 
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After being cultured, the cells are mixed with human lymphocytes, fixed in 70% ethanol (-20°C) 
and stored at -30°C pending analysis 
For analysis, 5 μΙ of each cell suspension was spotted onto Superfrost Plus glass slides 
(Merck, Darmstadt, Germany) and dried in air An appropriate part of each cell suspension, 
depending on cell density, was, after centrifugation, mixed with agar (volume 1 1), fixed in 
4% buffered formalin and embedded in paraffin wax 
Twenty formalin fixed, paraffin wax embedded cervical biopsy specimens (four normal, one 
cervical intraepithelial neoplasia (CIN) I, five CIN II, five CIN III, and five invasive carcinomas) 
were selected after histological examination of haematoxylm and eosm stained 4 pm tissue 
sections. 
Sections, 4 μιτι thick, of the paraffin wax embedded cell suspensions and samples of cervical 
tissue were mounted on Superfrost Plus glass slides and heated overnight at 60°C After 
dewaxmg in xylene and rinsing in methanol, endogenous peroxidase activity was blocked by 
incubating the slides with 1% h^CVmethanol for 20 minutes at room temperature. The slides 
were then rinsed in methanol and dried in air 
In situ hybridisation 
Ethanol fixed cell samples and paraffin wax sections were pretreated as described previously 
(1,14) Preteatment included the elimination of basic proteins and digestion by pepsin 
(Sigma, St Louis, Missouri, USA) DNA probes specific for HPV types 16 and 18 were 
labelled by nick translation with biotin-14DATP, as described by the manufacturer (BRL, 
Gaithersburg, Maryland, USA) The hybridisation mixture (15 μΙ) contained 60% deiomsed 
formamide (Merck), 10 % dextran sulphate (Sigma), 2x SSC (pH 7 0; 1x SSC = 0.15 M 
sodium chloride, 0.015 M sodium citrate), 50 ng/μΙ herring sperm DNA (Boehringer, 
Mannheim, Germany) and 2 ng/μΙ probe. The slides were heated for three minutes at 95°C 
(cytospin preparations) or for 10 minutes at 80°C (paraffin wax sections) to denature the 
probe and target DNA. After hybridisation overnight at 37°C in a moist chamber, coverslips 
were removed by immersing the slides in 2x SSC (pH 7 0) at 42°C. Posthybridisation washes 
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Table 1. Comparison of the sensitivity and specificity of the standard ISH and CARD-
ISH methods in the detection of HPV DNA in human cervical cancer cell 
lines. 
Cell line HPV type ISH CARD-ISH 
In suspension 
CaSki 16 
18 
HeLa 16 
18 
SiHa 16 
18 
Human 16 
lymphocytes 18 
In paraffin wax 
CaSki 16 
18 
HeLa 16 
18 
SiHa 16 
18 
Human 16 
Lymphocytes 18 
Score: -, no signal; + to ++++++, weak to very strong signal 
at 42°C were carried out twice for five minutes in 60% formamide/2x SSC, pH 7.0, and twice 
for five minutes in 2x SSC, pH 7.0. The slides were then rinsed in phosphate buffered saline 
(PBS)/0.05%Tween-20. 
Hybridised DNA probes were detected immunohistochemically using the HRP labelled 
avidin-biotin-complex (ABC) method (15) as described previously (1). HRP was visualised via 
the diaminobenzidine (DAB, SigmayHsOs (Merck) reaction. 
Card-ISH signal amplification 
Briefly, the slides were pretreated using the ABC method, incorporating mouse anti-biotin 
(MaB), biotinylated horse anti-mouse (HsaMbio), and ABC. After rinsing the slides in 
PBS/Tween and PBS, biotinylated tyramine was covalently bound to electron rich moieties 
on the surface through the enzymatic reaction of HRP with 0.01 % H2O2, in PBS for two 
minutes at room temperature (2). A biotinylated tyramine concentration of 0.7 μΜ was used 
for the cell suspensions and of 0.07 μΜ for the paraffin wax samples. After rinsing in 
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PBS/Tween, samples were incubated in ABComplex for 20 minutes at 37°C to detect the 
new biotin source Finally, the hybrid was visualised using DAB/H2O2 as described earlier 
Controls 
The specificity of the ISH reactions was defined by performing CARD-ISH with an HPV type 
18 DNA probe on cells containing HPV type 16 (CaSki and SiHa cells) and ISH with the HPV 
type 16 probe on HeLa cells, which contain copies of HPV type 18 None of the controls gave 
specific ISH signals The addition of human lymphocytes to the cell suspensions served as 
an internal negative control for all HPV DNA probes 
Table 2. Detection of HPV DNA in cervical lesions of 20 women by ISH and PCR. 
Case 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
Histology 
Normal 
Normal 
Normal 
Normal 
CIN 1 
CIN II 
CIN II 
CIN II 
C INI ! 
CIN II 
CIN III 
CIN III 
CIN III 
CIN III 
CIN III 
Invasive cancer 
Invasive cancer 
Invasive cancer 
Invasive cancer 
Invasive cancer 
HPV typing 
ISH 
ABC 
0 
0 
0 
0 
16 
16 
0 
0 
16 
0 
0 
16 
16 
16 
0 
0 
16 
0 
16 
0 
Card 
0 
0 
0 
0 
16* 
16* 
0 
16 
16* 
0 
16 
16* 
16* 
16* 
0 
16 
16* 
0 
16* 
16 
PCR 
0 
0 
0 
0 
X 
16 
0 
0 
16 
X 
16 
16 
16 
16 
0 
16 
16 
0 
16 
16 
0 = No HPV DNA detected, X = unidentified HPV type; * signal amplification 
Evaluation of ISH signals 
ISH signals were evaluated using a Leitz DMRB/E microscope and Wild 48/52 photographic 
equipment (Leica, Wetzlar, Germany). 
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Results 
Detection of HPV DNA in cell suspensions 
Table 1 summarises the results of standard ISH and CARD-ISH on CaSki, HeLa and SiHa 
cells. Figure 1 shows the results of routinely applied ISH compared with the CARD-ISH 
signal amplification method for the detection of HPV DNA in suspensions of HPV containing 
cell lines mixed with human lymphocytes. 
•v I 
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Figure 1 Results of CARD-ISH signal amplification on cervical cancer cell lines. (A) and (B) 
CaSki cells hybridised with a blotlnylated DNA probe specific for HPV type 16. (C) and (D) 
HeLa cells hybridised with a blotlnylated DNA probe specific for HPV type 18. (E) and (F) 
SIHa cells hybridised with a blotlnylated DNA probe specific for HPV type 16. Visualisation 
was achieved using the standard ABC technique (A, C, E), and by the CARD method (B, D, 
F). Human lymphocytes served as an internal negative control. Original magnification X400. 
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Figure 1A shows HPV type 16 in CaSki cells, detected using the conventional ABC method 
Figure 1B shows the results of the CARD-ISH signal amplification method. Weak 
hybridisation signals were observed using the conventional ABC method for the detection of 
HPV type 18 DNA in HeLa cells (Figure 1C) In comparison, application of the CARD-ISH 
signal amplification method gives very strong hybridisation signals (Figure 1D) In figure 1F 
one to three copies of HPV type 16 DNA in SiHa cells were visualised using the CARD-ISH 
method, which is not possible using the conventional ABC procedure (Figure IE) 
Detection of HPV DNA in paraffin wax sections 
Cell suspensions fixed in formalin and embedded in paraffin wax 
HPV DNA was detected in CaSki cells (Figures 2A and 2B), HeLa cells (Figures 2C and 2D) 
and SiHa cells (Figures 2E and 2F) using the conventional ISH and CARD-ISH signal 
amplification methods, respectively As can be seen in figures 2B, 2D, and 2F, the 
hybridisation signals generated after CARD-ISH are more intense compared with those 
generated using the conventional ISH method Moreover, in figure 2E no hybridisation 
signals are visible in SiHa cells, whereas in figure 2F one to three signals can be seen 
Paraffin wax sections of cervical biopsy specimens 
Table 2 summarises the results of CARD-ISH The results were compared with the standard 
ISH ABC method and HPV PCR analysis of the same samples. Figures 3A and 3B show ISH 
results of case 11 hybridised with the HPV type 16 DNA probe. The sample was HPV 
negative on conventional ISH (Figure 3A) but after CARD-ISH the sample is clearly HPV 
positive (figure 3B). A representative case (case 14) is shown in Figures 3C and 3D. HPV 
DNA was not detected on conventional ISH (Figure 3C), on CARD-ISH, however, HPV DNA 
is clearly visible in the nuclei (Figure 3D) No ISH signals were detected on hybridisation of 
parallel tissue sections with the HPV type 18 DNA probe and the unlabelled HPV type 16 
DNA probe (not shown). 
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Figure 2 Results of CARD-ISH signal amplification on paraffin wax sections of cell 
suspensions (see Methods). (A) and (B) CaSki cells hybridised with a DNA probe specific for 
HPV type 16. (C) and (D) HeLa cells hybridised with a DNA probe specific for HPV type 18. 
(E) and (F) SiHa cells hybridised with a DNA probe specific for HPV type 16. Visualisation 
was achieved using the standard ABC technique (A, C, E), and by the CARD method (B, D, 
F). Human lymphocytes served as an internal negative control. Original magnification x400 
(Α-D); xlOOO (E and F). 
Discussion 
Recently, we described a fast and highly sensitive ISH method (CARD-ISH) for the routine 
detection of low copy number genome sequences in morphologically intact cells (1,5). In the 
present study we have compared the sensitivity of this CARD-ISH method with a standard 
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ISH method for the in situ detection of integrated HPV DNA sequences The latter was 
carried out using the most sensitive conventional immunochemical detection method, that is 
the ABC method CaSki, HeLa, and SiHa cell lines were used as model systems because the 
relative amount of HPV 16 (CaSki >500 copies/cell, SiHa one to three copies/cell) and HPV 
18 (HeLa 20-50 copies/cell) per cell is known (16) We found that the CARD-ISH method is 
more sensitive than conventional ISH and is capable of detecting HPV 16 in SiHa cells 
(Figures IF and 2F) using full length DNA probes, which is in sharp contrast to ISH alone 
(17) By using CARD-ISH signal amplification minor binding sites may become apparent in 
some control cells This non-specific binding can be avoided by adjusting the recommended 
dilution of the mouse anti-biotin antibody (1 in ΙΟ4 instead of 1 in 102) Conditions for the 
CARD-ISH signal amplification protocol can also be optimised by adjusting the biotmylated 
tyramme concentration or the incubation time, or both, in combination with an appropriate 
MaB dilution (1) To detect HPV DNA using CARD-ISH, the highest degree of signal 
amplification with the highest signal to noise ratio can be obtained for tissue sections by 
incubating them with a 1 in IO3 dilution of MaB and 0 07 μΜ biotmylated tyramme for five 
minutes (Figure 3) 
Cervical carcinoma is one of the most common cancer types in the developed world As the 
prognosis of cervical cancer is good if caught and treated early, and given the causal 
association between infection with high risk HPV types and cervical carcinoma (6-9), it is vital 
that women infected with these high risk HPV types are identified Recently, it has been 
shown that worldwide at least 93% of cervical carcinomas are HPV DNA positive (18) In 
addition to HPV types 16 and 18, 13 other oncogenic HPV types have been identified (19) In 
the present study we used probes for HPV types 16 and 18 for ISH and a general HPV probe 
(primer X) for PCR This may explain the discrepancies between our ISH and PCR results for 
cases 5 and 10, but not for case 8 (Table 2) At present, the most sensitive method available 
for the detection of HPV in clinical samples is general primer mediated PCR (19) or PCR-ISH 
(10) With our fast and highly sensitive CARD-ISH method it is possible to detect HPV DNA 
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types 16/18 sequences in morphologically preserved samples without the need for PCR 
amplification (Table 2, Figure 3) Work to develop a procedure that combines the CARD-SH 
method with a general oncogenic HPV DNA probe that specifically recognises all 15 
oncogenic HPV types is underway. 
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Figure 3 Results of CARD-ISH signal amplification on tissue sections from cases 11 (A and 
B) and 14 (C and D), both classified histologically as CIN III. ISH was done with a biotinylated 
DNA probe specific for HPV type 16 sequences. Visualisation was achieved using the 
standard ABC technique (A and C) and the CARD-ISH signal amplification method (B and 
D). Original magnification x250 (A and Β); X400 (C and D). 
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The distribution pattern of HPV DNA is related to the degree of cellular differentiation and 
viral DNA is most abundant in the more superficial cells (20). Whether the virus is also 
present in the less differentiated basal cells is unknown, as routine ISH is limited by its in situ 
detection threshold of about 20 copies per cell (18). Therefore, we have investigated the 
cellular localisation of HPV DNA in paraffin wax sections of a large series of cervical lesions 
using the CARD-ISH method 
In conclusion, CARD-ISH is a fast and highly sensitive ISH method for the routine detection 
of low copy number HPV DNA sequences in cervical cell lines and routinely processed tissue 
sections. Application of this technology also enables the routine detection and cellular 
localisation of other viral DNA sequences present at copy numbers below the detection limit 
of conventional ISH methods 
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Summary 
The aims of this study were to assess the relation between numerical aberrations for 
chromosome 1 and the presence of high-risk HPV 
Therefore, 11 CIN1, 15 CIN2, 20 CIN3, 9 invasive carcinomas, and 5 normal samples were 
studied by in situ hybridization (ISH) on serial 3^m-thick paraffin tissue sections, by using a 
centromenc DNA probe for chromosome 1 and a DNA probe for HPV16/18 A PCR 
technique was used to detect any HPV type The chromosome index (CI) was measured, 
and the fractional area of dysplastic epithelium with aneusomy and infection with HPV16/18 
were estimated 
Disomy was found in all normal epithelium and in 36% of CIN1 Tetrasomy was observed in 
64%, 27%, and 15% of CINI, CIN2, CIN3, respectively Infection with HPV was detected in 
78% of the tetrasomic lesions Hyper-tetrasomy was observed in 67%, 85%, and 100% of 
CIN2, CIN3, and invasive carcinomas, respectively High-risk HPVs were present in 89% of 
hyper-tetrasomic lesions, and the mean CI value in HPV negative lesions was lower than in 
HPV positive lesions (p=0 03) In 77% of the HPV16/18 positive CIN lesions, the fractional 
area of HPV infected epithelium was equal to or greater than that with aneusomy 
In conclusion, aneusomy for chromosome 1 is highly associated with high-grade CIN lesions 
and infection with high-risk HPV Aneusomy for chromosome 1 seems to be a promising 
surrogate biomarker for the prediction of progressive behavior in low-grade CIN lesions 
Introduction 
Epidemiological, climcopathological, and molecular biological studies have established that 
human papillomavirus (HPV) is strongly associated with the development of premalignant 
cervical lesions (1,2,3,4,5) Of the more than 90 identified HPV types, HPV 16, 18, 31, 33, 35, 
45, 51, 52, 56 and 58 are regarded as high risk viruses, because these viruses are frequently 
present in high-grade cervical intraepithelial neoplasia (CIN) and cervical cancer (6,7,8) Several 
studies have evaluated the use of HPV testing as a prognostic marker in addition to cytological 
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screening of cervical smears (7,9,10,11,12) These data suggest that the detection and typing of 
HPV is a useful adjunct to the Papanicolaou stained cervical smear (Pap smear), and that 
diagnosis of a particular HPV infection may dictate a particular clinical outcome and hence be 
useful in patient management 
The discovery that HPV E7 protein can bind to pRb and that the E6 protein can breakdown p53 
was important to understand the role of HPV infection in the oncogenesis of cervical cancer 
Inactivation of pRb and p53 leads to hyperprohferation and genetic instability, respectively 
Genetic abnormalities, as shown by abnormal DNA contents or numerical chromosome 
aberrations have been shown to be important biological markers for the progression of CIN 
towards cervical cancer (13-19) In CIN1 lesions, tetrasomy for chromosomes 1, 3, 11, 17, 18, 
and X was exclusively found in cases infected by high-risk HPV types (17) In another 
cytogenetic study, numerical aberrations for these six chromosomes were found in 44% and 
72% of CIN3 and invasive carcinomas, respectively All CIN3 lesions in this study were infected 
with high-risk HPV types, whereas two of 25 carcinomas were not infected by high-risk HPV 
(19) Recently, we found aneusomy for the chromosomes 1, 3 6, 7, 8, 11, 17, and X in 94% of 
CIN lesions and all invasive carcinomas In addition, the chromosome indices of chromosomes 
1, 7, and X were positively correlated with the CIN grade (18) In the latter study, the 
topographical relation between numerical chromosome aberrations and the presence of HPV 
was not assessed Our knowledge about the area of dysplastic epithelium infected by HPV and 
the area of epithelium with numerical chromosome aberrations is incomplete Based on the the 
assumption that HPV infection precedes genomic instability, it is hypothesized that the epithelial 
area with numerical chromosome aberrations is smaller than the area infected with HPV In this 
study, we used the highly sensitive catalyzed reporter deposition amplified ISH procedure 
(CARD-ISH) for topographical detection of HPV 16/18 DNA sequences in routinely processed 
tissue sections (20,21) In a serial paraffin tissue section, the copy number for chromosome 1 
was identified by ISH using a pen-centromenc probe specific for chromosome 1 All cervical 
lesions were also tested for the presence of any HPV type by PCR 
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The aims of this study were' 1) to assess numerical aberrations for chromosome 1 in high-risk 
HPV infected and non-infected CIN lesions and invasive carcinomas, and 2) to assess the 
relation between the fractional area of dysplastic cervical epithelium infected by HPV16/18 and 
the fractional area of dysplastic epithelium with aneusomy for chromosome 1. 
Materials and Methods 
Patients 
Paraffin-embedded tissue sections of sixty patients were used, including 46 cases of CIN, 9 
cases of invasive carcinoma and 5 cervical biopsies without histopathological abnormalities. 
Two pathologists independently graded the CIN lesions Grading of CIN was done according to 
the generally accepted cntena (22,23,24) The grading results were as follows' 11 cases with 
CIN1, 15 cases with CIN2 and 20 cases with CIN3 In case of discrepancy, the final grade of 
CIN was obtained by consensus with a third pathologist 
DNA probes for ISH 
The centromere-associated DNA probe pUC 1 77 was used for the detection of chromosome 
1 (25) The DNA probe specific for HPV types 16/18, as well as the centromere probe for 
chromosome 1, were labelled by nick translation with biotin-14-dATP, as described by the 
manufacturer (BRL, Gaithersburg, Maryland, USA) 
In situ hybridisation 
The ISH procedure with centromere probe for chromosome 1 and the HPV 16/18 probe on 3 
μπνΙΙπ^ paraffin sections were performed as described previously (18,20). In short, after 
tissue pretreatment, overnight hybridization and stnngent washings, demonstration of the 
biotinylated DNA-DNA hybrids was performed using the HRP labelled avidin-biotm-complex 
(ABC) method (26). For detection of low copy number HPV 16/18 DNA sequences, a catalyzed 
reporter deposition ISH (CARD-ISH) signal amplification procedure was performed (20,26). 
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After consecutive immunodetection steps with mouse-anti-biotm (MaB), biotmylated horse anti-
mouse (HsaM-bio), and ABC, the slides were further incubated with biotin-tyramme solution 
(0.07 pmol/l) and 0.01 % H2O2 for 2 minutes at room temperature Subsequently, the biotm 
complex was detected by a second incubation step with ABC for 20 minutes at 37 0C The 
peroxidase-labelled complex was visualized by precipitating diaminobenzidme (DAB, Sigma) 
through the reaction of horseradish peroxidase and H£>2 and intensified with 0 5 % CUSO4 
Finally, the slides were slightly counterstained with Mayer's haematoxylm 
Polymerase Chain Reaction 
A single 3 pm-thick tissue section was put into a reaction tube and incubated overnight at 56 
°C in 200 μΙ 10 mM Tns-HCI with 1 mM EDTA, 0.2% Tween-20 and proteinase Κ (0,3 mg/ml) 
Proteinase Κ was inactivated by 10 mm incubation at '\00oC. The sample was centrifuged for 
10 mm at 11,000 rpm and 10 μΙ was directly used for PCR analysis A water blank control 
was processed with each batch of 10 samples. 
We assessed HPV-DNA status by a general primer-mediated polymerase chain reaction 
(PCR) using HPV-L1 consensus primers which amplifies a fragment of 450 base-pairs of a 
broad range of specified genital HPV types as well as unidentified HPVs (HPV X) All HPV 
DNAs that were amplified with the consensus primers were PCR sequenced using the Perkm 
Elmer AmphCycle sequencing kit (Roche Molecular Systems, Ine , Branchburg, New Jersey) 
Sequenced HPV DNA fragments were compared with the GenBank to determine the HPV 
type (27) 
Evaluation of ISH and CARD-ISH 
Tissue sections with non-overlapping and morphologically good preserved nuclei with 
separated ISH signals were evaluated as reported earlier (18) Regions of the dysplastic 
epithelium were considered to have aneusomy for chromosome 1 when multiple nuclei with 
more than two ISH signals per nucleus were present. Actual aneusomic populations within 
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the CIN lesions were identified by the presence of three or more signals in> 10% of nuclei as 
previously reported and validated for paraffin section analysis (28) 
Within CIN lesions, regions of dysplastic epithelium with and without aneusomy for 
chromosome 1 were demarcated Subsequently, the lengths of the selected regions parallel 
to the mucosal surface were manually measured From these two values the fraction of 
dysplastic epithelium with aneusomy for chromosome 1 (fractional area) was determined and 
expressed as a percentage Two investigators separately measured the fractional area with 
aneusomy There was a good agreement between these two investigators and the 
differences for each case were not more than 10% Subsequently the number of ISH signals 
per nucleus was counted in 100 nuclei in normal cases, in normal epithelium adjacent to CIN 
lesions, in CIN lesions, and in squamous cell carcinomas In parallel sections the in situ 
presence and the extension of HPV DNA type 16/18-positivity was determined In the CIN 
lesions, the fractional area of dysplastic epithelium positive for HPV16/18 was measured in 
the same way as for the fractional area with aneusomy of chromosome 1 In addition, the 
difference between fractional area of dysplastic epithelium infected by HPV16/18 and 
fractional area with aneusomy for chromosome 1 was calculated 
The CI is defined as the mean number of chromosome copies per nucleus in the sample of 
measured nuclei The CI measured in non-truncated diploid nuclei has a theoretical value of 
2 In truncated nuclei, the CI measured in diploid cells, will be always smaller than 2 As 
pointed out in an earlier study, an aberrant CI was defined as any value of CI greater than 
1 4 (mean value CI plus 2 58 χ SD, obtained from normal cervical epithelium in control 
subjects)(18) The women in the present study are subdivided in three groups on the basis of 
CI and the number of ISH signals per nucleus The first group consisted of cases with CI < 
1 4 (disomic) The second group of cases had CI > 1 4 and no cells with more than 4 ISH 
signals per nucleus (tetrasomic) The third group of cases had CI > 1 4 and cells with 5 or 
more ISH signals per nucleus (hyper-tetrasomic) 
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Statistics 
The statistical analysis and graphical representations of the data were performed with SPSS 
8.0 for Windows (SPSS INC., Michigan, USA). The differences between the diagnostic 
groups were assessed by two factorial analysis of variance (ANOVA). Prior to the use of 
ANOVA the Lillifors test of normality was performed. When a significant difference between 
the different diagnostic groups was found by ANOVA, a modified least significant difference 
(LSD) test according to Bonferroni was used to elucidate which groups were mutually 
different. 
Table 1. Results of HPV detection by ISH-CARD and PCR. 
Diagnosis ISH-CARD 
HPV 16/18 PCR 
TOTAL 
Normal 
CIN1 
" 
4 
1 
7 
2 
+ 
2 
HPV 
-
4 
7 
2 
HPV 
16 
HPV 
33 
1 
HPV 
58 
1 
1 
HPV 
X 
4 
1 
7 
2 
2· 
8 
3 
CIN 2 
CIN 3 
1 
1 
1 
1 
1 
17 
1 
1 
1 
1 
1 
1 
17 
1 
1 
1 
4 ' 
17 
j · 
InvCa 
1 1 
5 
3 
1' 
'Cases in which HPV CARD-ISH test is not in agreement with PCR test. 
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Results 
HPV detection by PCR and ISH-card procedure 
The frequencies of HPV types as detected by ISH-CARD and PCR in the control group, CIN 
lesions, and invasive carcinomas are summarized in Table 1 Accordance between the two 
virus detection methods (ISH-CARD and PCR) was found in 53 of 60 cases (88%), in all 
normal cases, 9 of 11 CIN 1 lesions, 13 of 15 CIN 2 lesions, 18 of 20 CIN 3 lesions, and 8 of 
9 invasive carcinomas The best agreement (98%) between PCR and ISH-CARD was found 
in the group of PCR HPV16 positive cases (31 cases). In this group, the ISH-CARD missed 
one case. In 8 HPV16/18 negative cases in ISH-CARD, the PCR test detected HPV16, 
HPV33 and HPV58 in 1, 4 and 3 cases, respectively 
In the 37 ISH-CARD HP\/16/18 positive cases, the fraction of virally infected dysplastic 
epithelium varied from 5% to 100% 
Chromosome index in normal epithelium 
The mean values, SD, minimum and maximum values of CI in the cervical epithelium of the 
control group and in the normal epithelium adjacent to CIN or invasive carcinoma are given 
in Table 2 ANOVA did not disclose significant differences between the diagnostic groups 
with regard to CI The overall mean and SD for normal epithelium in the 60 cases of this 
study are 1 22 ± 0 06 
Table 2. The mean values, standard deviation, minimal and maximum values of CI for 
chromosome 1 in normal subjects and in normal epithelium adjacent to CIN 
or invasive carcinomas. 
Diagnosis Mean ± SD Min. Max. 
Normal 1 20 ± 0.06 ÏTÏ2 ÏT27 
CIN1 1 23 ±0.04 1 14 1.29 
CIN2 121 ±0 07 1.11 1.37 
CIN3 1.21 ±0.08 101 1.33 
InvCa 124 ±0 07 1.13 1.36 
Overall 122 ±0.06 1.01 1.37 
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Chromosome Index in CIN and invasive carcinoma 
The mean CI values found of HPV-positive and -negative control subjects, CINI, CIN2, 
CIN3, and invasive carcinomas are presented in Figure 1. Two-factorial ANOVA disclosed 
highly significant differences between the different diagnostic groups (p<0.001). The 
difference between HPV positive and negative lesions was weakly significant (p=0.02). The 
Bonferroni LSD test for multiple comparisons revealed no significant differences between 
normal epithelium and CIN1. The differences between CINI and the high-grade CIN lesions 
and invasive carcinomas were highly significant (p<0.001). The mutual differences between 
CIN2, CIN3, and invasive carcinomas were not significant at the significance level of 0.05. 
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Figure 1. The mean value of CI and 2xSE for HPV positive (m) and negative (·) normal 
subjects, CIN1, CIN2, CIN3 lesions, and invasive carcinomas. 
Disomy was observed in the 5 control subjects and in 5 of 55 CIN lesions (4 CIN1 and 1 
CIN2). In the group of 11 CINI lesions, 7 cases (64%) were tetrasomic, while hyper-
tetrasomy did not occur. In the group of 15 CIN2 lesions, the percentages of disomy, 
tetrasomy, and hyper-tetrasomy were 7% (1/15), 27% (4/15), and 67% (10/15), respectively. 
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In the group of CIN3 and carcinomas, no patients with disomy for chromosome 1 were 
present. Hyper-tetrasomy was observed in all carcinomas, and in 85% (17/20) of CIN3 The 
mean values and SD of CI for the disomic, tetrasomic and hyper-tetrasomic cases were 
1.25±0 08, 1.88±0.21, and 2.35±0 32, respectively (Table 3). The mutual differences of CI 
between the disomic, tetrasomic, and hyper-tetrasomic cases were highly significant 
(p<0.001). 
Table 3. Mean values of CI and standard deviations for HPV positive and negative 
cases, subdivided in disomic, tetrasomic, and hyper-tetrasomic cases. 
DISOMIC CASES TETRASOMIC CASES HYPER-TETRASOMIC CASES 
Diagnosis 1.25 ±0.08 1.88+0.21 2.35±0.32 
HPV POS. HPV NEG. HPV POS. HPV NEG. HPV POS. HPV NEG. 
60 Ν CI±SD Ν CI±SD Ν CI±SD Ν CI±SD Ν CI±SD Ν CI±SD 
Control ί Γ Ί Γ Ϊ 2 4 Γ22±0 05 Ö Ö 5 Ô 
CIN1 11 0 4 128±0 07 4 180+0 25 3 1 74±0 16 0 0 
CIN2 15 1 1 37 0 4 1 90±014 0 10 2 33±0 34 0 
CIN3 20 0 0 3 2 09±0 14 0 16 2 39±0 31 1 2 29 
INV. CA 9 0 0 0 0 6 2 50±0 32 3 1.95±0 20 
Three-factonal ANOVA performed on the CI measurements of the whole group of 60 women 
disclosed that after inclusion of the ploidy group (disomy, tetrasomy, and hyper-tetrasomy) in 
the ANOVA the differences between the five diagnostic groups were not significant. The 
differences between the disomic, tetrasomic and hyper-tetrasomic lesions were highly 
significant (p<0 001) and the effect of HPV infection on CI was weakly significant (p=0.03). 
Pairwise comparisons by the Bonferrom LSD test disclosed significant differences of CI 
between disomic and tetrasomic (p=0 001), disomic and hyper-tetrasomic (p<0.001), and 
tetrasomic and hyper-tetrasomic (p=0.003) 
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A two-factorial ANOVA disclosed no significant differences between the different diagnostic 
groups and HPV positive and negative lesions in both the groups of disomic and tetrasomic 
lesions In the group of hyper-tetrasomic lesions, the mean Cl-value of the HPV negative 
lesions was significantly lower than in the group of HPV positive lesions The Cl-values of 
CIN2, CIN3, and invasive carcinomas did not differ at a significance level of 0 05 
Frequency distributions of ish signals in disomic, tetrasomic and hyper-tetrasomic 
lesions 
The frequency distributions of cells with 0, 1, 2, 3, 4, 5, 6, 7, and 8 ISH signals for 
chromosome 1 per nucleus are presented for all disomic, tetrasomic, and hyper-tetrasomic 
cases in Figure 2A In the group of hyper-tetrasomic cases, few cells with more than 6 ISH 
signals per nucleus were found 
In the group of tetrasomic cases, there are only minor differences between the CINI, CIN2, 
and CIN3 lesions (Figure 2B) The differences between CIN1, CIN2, and CIN3 lesions were 
weakly significant for the percentages of cells with 0 ISH signals per nucleus (p=0 02) and 
with 1 ISH signal per nucleus (p=0 04) No significant differences were found between the 
different CIN grades for the percentages of cells with 2, 3, and 4 copies per nucleus at a 
significance level of 0 05 The differences between HPV positive and negative lesions were 
not significant Bonferrom LSD test disclosed a significant difference between CINI and CIN2 
for the fraction of cells with 0 ISH signals per nucleus (p=0 02), and between CIN1 and CIN3 
for the fraction of cells with 1 ISH signal per nucleus (p=0 04). 
In the group of hyper-tetrasomic cases, there are also minor differences between CIN2, 
CIN3, and invasive carcinoma (Figure 2C) The differences between these diagnostic groups 
and between the HPV positive and negative lesions were not significant for the fractions of 
cells with 0, 1,2, 3, 4, 5, 6, 7, and 8 ISH signals per nucleus at a significance level of 0 05 
Therefore, the mean values of CI found in the different diagnostic groups (Figure 1) may be 
explained by the frequencies of disomic, tetrasomic, and hyper-tetrasomic lesions in the 
diagnostic groups 
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CIN2 CIN3 INV CA 
Figure 2. The fractions of cells with 0, 1, 2, 3, 4, 5, 6, 7, and 8 ISH signals per nucleus of 
disomic, tetrasomic, and hyper-tetrasomic lesions are given as percentage (2A). The 
frequency distributions of cells with 0, 1, 2, 3, 4, 5, 6, 7, and 8 ISH signals per nucleus of 
tetrasomic CIN1, CIN2, and CIN3 lesions (2B), and the frequency distributions of hyper-
tetrasomic CIN2, CIN3, and invasive carcinoma (2C). 
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Figure 3. Differences in fractional areas of dysplastic epithelium infected by HPV 16/18 and 
areas with aneusomy for chromosome 1 (fractional area HPV infected minus fractional area 
with aneusomy for chromosome 1) for each of the 31 CIN lesions with HPV16/18 detected by 
ISH-CARD (CIN1=0. CIN2=o, and CIN3=a) 
Fractional area with aneusomy and HPV16/18 
The ISH-CARD HPV16/18 detection method was positive in 31 CIN lesions (Table 1) For 
these cases, the differences between the fractional area of dysplastic epithelium infected by 
HPV16/18 (ISH-CARD) and the fractional area with aneusomy for chromosome 1 are given 
in Figure 3 No substantial differences between the fractional areas with aneusomy and HPV 
infection, defined by an absolute value of the differences between the two fractional areas< 
10, were found in 7/31 (22%) cases In only 4/31 (13%) cases the fractional area with 
aneusomy was greater than the fractional area infected by HPV 16/18 (Figure 3) In 20/31 
(65%) cases the fractional area infected by HPV was greater than the fractional area with 
aneusomy (Figure 3) ANOVA disclosed no significant differences between the CIN grades 
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Discussion 
In the present study, aneusomy for chromosome 1 was found in seven of the 11 CIN1 
lesions, and all 7 aneusomic CIN1 lesions were classified as tetrasomic lesions In a 
previous study, it was shown that the mean values of CI for chromosomes 1, 7, and X 
gradually increased with the increase of the CIN grade (18) The results of the present study 
disclosed that this gradual increase of CI is caused by the increasing prevalence of hyper-
tetrasomic lesions with the increase of the CIN grade The prevalences of hyper-tetrasomy 
for chromosome 1 were 0%, 67%, 85%, and 100% for CINI, CIN2, CIN3, and invasive 
carcinoma, respectively However, in the group of hyper-tetrasomic lesions no significant 
differences between CIN2, CIN3 and invasive carcinoma were found with regard to mean 
values of CI and the frequency distributions of cells with 0, 1, 2, 3, 4, 5, 6, 7, and 8 ISH 
signals per nucleus. In the group of tetrasomic lesions, no significant differences between 
CIN1, CIN2, and CIN3 lesions could be detected for the CI and only minor differences for the 
frequency distributions of cells with 0, 1, 2, 3, and 4 ISH signals of chromosome 1 per 
nucleus. 
Our observations in CIN3 lesions and invasive carcinomas differed from those of another 
interphase cytogenetic study (19) In that study, disomy was found in 56% of the CIN3 
lesions and 28% of invasive carcinomas, whereas we found that none of the CIN3 lesions 
and invasive carcinomas exhibited disomy for chromosome 1 Our observed high prevalence 
of hyper-tetrasomy in high-grade CIN lesions and invasive carcinomas are more in 
agreement with the results of recent DNA ploidy studies, in which DNA aneuploidy was found 
in more than 90% of cases (14,29,30,31,32). In our series, disomy was found in 36% of the 
CIN1 and one of 15 CIN2, as well as in the control subjects and the histomorphologically 
normal epithelium adjacent to CIN lesions The latter observation is also reported by other 
investigators (17) 
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Aneusomy for chromosome 1 is highly associated with infection with high-risk HPV In the 
present study, infection with high-risk HPV was found in 20%, 79%, and 89% of the lesions 
with disomy, tetrasomy, and hyper-tetrasomy, respectively In another interphase cytogenetic 
study it was shown that all tetrasomic CIN1 lesions were infected with high-risk HPV types, 
whereas none of low-grade CIN lesions infected with low-risk HPV types exhibited basal cell 
tetrasomy (17). Therefore, the authors suggested that induction of chromosome instability 
may be a mechanism underlying the biological differences between high-risk and low-risk 
HPV types The latter findings are in agreement with the observation that the E6 and E7 
oncoproteins of the high-risk HPVs have higher affinity for p53 and pRb than those of the 
low-risk HPVs (33) The mactivation of pRb and p53 by the oncogenic viral proteins E7 and 
E6, respectively, results in hyperproliferation, immortalisation and genetic instability of the 
cervical epithelial cells and ultimately in the development of cervical cancer (34-37) An early 
phenomenon of genetic instability is tetraploidization, because it is observed much more 
frequently in low-grade CIN lesions than in high-grade CIN lesions. We found tetrasomy for 
chromosome 1 in 64% of CIN1 lesions and in only 15% of the CIN3 lesions. It seems likely 
that progression is associated with hyper-tetrasomy for chromosome 1 as shown in the 
present study, but gams of selected chromosomes may also be involved in progression (18) 
In addition to these numerical chromosome aberrations detected by ISH techniques, gam of 
3q was found by comparative genomic hybridization as the most consistent structural 
chromosomal aberration that was observed in 35% of pre-mvasive lesions and in 72% of 
cervical carcinomas (38) 
In the invasive carcinomas HPV16/18 positive cells were diffusely distributed throughout the 
tumors In 24 of the 31 CIN lesions (77%) studied by CARD-ISH technique, the fractional 
area of dysplastic epithelium infected with HPV16/18 was equal or in most cases greater 
than the fractional area of dysplastic epithelium with numerical chromosome aberrations The 
viral oncogenesis model in which viral infection is needed to inactivate pRb and p53, 
necessary to induce genetic instability, could explain these findings (34-37) 
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In spite of the use of the highly sensitive CARD-ISH technique for HPV16/18, in four of the 
31 CIN lesions, we found that the fractional area of dysplastic epithelium with aneusomy for 
chromosome 1 exceeded the fractional area of epithelium infected with HPV16/18 with ten or 
more percent. In two of these lesions the difference was more than 40% These observations 
suggest that aneusomy may occur in dysplastic epithelium in the absence of HPV We found 
tetrasomy in 3 of the 7 HPV negative CIN1 lesions, and even in 11% of the hyper-tetrasomic 
lesions we were not able to detect HPV. These findings support the hypothesis that in a 
minority of women aneusomy may occur in the absence of high-risk HPV (39,40) Recently, 
numerical aberrations for chromosomes 3, 7, and X in HPV-negative high-grade lesions were 
found (41) All these observations suggest that in a small group of women a HPV-
mdependent pathway may lead to high-grade CIN and cervical cancer 
The results of the present study demonstrated that the measurement of CI and frequency 
distributions in truncated nuclei of tissue sections is a useful procedure to investigate 
numerical chromosome aberrations in CIN lesions and invasive carcinomas However, this 
procedure has its limitations, because tissue sections of standardized thickness were needed 
and the actual CI could not be measured (42). In spite of these limitations, the cytogenetic 
classification of CIN lesions in disomic, tetrasomic, and hyper-tetrasomic lesions appeared to 
be valuable, as it is likely associated with progression and it informs the pathologist about the 
actual status of chromosome instability of the CIN lesion at time of biopsy The proposed 
cytogenetic classification of the CIN lesions can be also applied to cytological material, using 
the AgarCyto approach, a newly developed cell-embedding procedure (43) Currently, we 
performed a prospective study using AgarCyto specimens of mild or moderate dysplastic 
cervical lesions to investigate whether progressive or regressive behavior can be predicted 
on the basis of the chromosome index for chromosome 1 The preliminary results show that 
progression and regression can de predicted correctly in 85% of the cases on the basis of 
chromosome index, independent of the cytological grade or the presence of high-risk HPV 
types (unpublished results). 
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In conclusion, chromosome aberrations for chromosome 1 defined by a chromosome index 
greater than 1.4 and measured in 3 pm thick tissue sections is highly associated with high-
grade CIN lesions and infection with high-risk HPV types Aneusomy for chromosome 1 
seems to be a promising surrogate biomarker for the prediction of progressive behavior in 
low-grade CIN lesions, even in the absence of high-risk HPV types 
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Summary 
This thesis focuses on cell hyperproliferation and on genetic abnormalities in both 
preneoplastic epithelia of the human cervix uteri and cervical cancer Climcopathological and 
epidemiological studies clearly demonstrated the central role of human papilloma virus (HPV) 
in cervical carcinogenesis Molecular data originating from in vitro studies of cervical 
carcinoma cell lines clearly give evidence that oncogenic HPV can bind and break down two 
tumor suppressor proteins that are pivotal in the cell cycle pRb and p53 As pRb functions 
as a "brake" of the cell cycle and p53 "guards' the stability of the genome, inactivation of 
these proteins gives rise to enhanced cell division (hyperproliferation) and genetic instability, 
respectively 
In Chapter 1 an overview is given of the natural history of CIN as well as a description of the 
histopathology The important role that HPV plays in cervical carcinogenesis is stressed 
The preneoplastic stages of cervical cancer are subdivided in cervical intraepithelial 
neoplasia (CIN) grades 1 to 3 This classification is important, as high-grade CIN (CIN2 and 
CIN3) needs an adequate surgical intervention because of the high progression tendency 
On the contrary, low-grade CIN (CIN1) can be left untreated or approached by a "wait and 
see" procedure as most of the latter lesions regress spontaneously However, in grading CIN 
and other benign cervical epithelial abnormalities as epithelial atrophy, pathologists rely on 
rather subjective morphological criteria The observation that increasing CIN goes together 
with enhanced proliferation of the cervical epithelium has led us to study in depth the 
application of proliferation-associated antibodies to classify CIN and other cervical epithelial 
abnormalities in a reproducible, objective and more reliable way 
135 
The three subsequent chapters are dedicated to proliferation in CIN lesions and "atypical" 
atrophy in postmenopausal women. Chapter 2 describes the application of the monoclonal 
antibody MIB1 in routinely processed tissue of normal and abnormal cervical epithelium 
(CIN1, CIN2 and CIN3). MIB1 recognizes an epitope of the proliferation-associated Ki-67 
antigen that is situated in the nucleus. The Ki-67 antigen is expressed during the mitosis (G,, 
S, and G2M phases), but not in Go of the cell cycle With the help of an image analysis 
system, four parameters associated with proliferation were measured. The grade of CIN 
highly correlated with all parameters (0 90<r<0 97, p<0 0001) The Ki-67 labelling index (LI) 
ranged from 0.07 ± 0 03 to 0.39 ± 0.06 for normal cervical epithelium and CIN3, respectively 
The 90th percentile of the relative distances of Ki-67-positive nuclei from the basement 
membrane displayed the best correlation (r=0 97, p<0 0001) 
Chapter 3 and 4 deal with the question whether MIBI-immunocytochemistry can be used to 
distinguish atrophic cervical epithelium and "atypical" atrophy from high-grade CIN. In daily 
diagnostic practice, cervical smears of postmenopausal women with epithelial atrophy may 
give diagnostic problems Due to reduced levels of ovarian hormones, proliferation and 
surface epithelial maturation are absent, and the morphological aspect of the cervical 
epithelium may be confused with high-grade CIN. As benign atrophic epithelium, in contrast 
to CIN epithelium, does mature into normal epithelium by estrogens, the cytopathologist will 
in this instance advice the gynecologist to repeat the cervical smear after a course of 
estrogens. 
A case-control study was performed on 83 patients and this group was subdivided in a 
training set of 32 cases and a test set of 51 cases. From the training set MIBI stained tissue 
sections as well as MIB1 restamed preceding cervical smears were studied In the tissue 
sections MIBI-positivity was determined using the earlier mentioned image analysis system 
For the restained cervical smears a point counting procedure was used to assess the 
proliferative activity index (PAI). Normal epithelium and cervical atrophy, exhibited significant 
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lower proliferative activity than CIN2 and 3, in both biopsies (LI 0 07 ± 0 01 and 0.02 ± 0 01 
vs 0 25 ± 0 05 and 0.41 ± 0 05, successively, p<0 001) and cervical smears (PAI. 0 01 ± 
0 02 and 0 04 ± 0 02 vs 0.34 ± 0.07 and 0 59 ± 0 07, successively, p<0 001). Application of 
the PAI-classifier obtained from the training set on the cases of the test set disclosed that all 
cases of cervical atrophy (n=25) and high-grade CIN (n=26) were correctly classified Finally, 
a PAI-based diagnostic decision tree for postmenopausal women was designed. If PAI < 
0 10, the patient will be referred to the regular screening program because the probability 
that she has high-grade CIN is < 0 1% and if PAI ^ 0.25, she will be referred to the 
gynecologist because the probability that high-grade CIN is present is> 99.9% Restained 
cervical smears with PAI values between these thresholds will be repeated after an estrogen 
course The application of such a decision tree will result in an expected reduction of cases 
who need an estrogen course of at least 90% 
Subsequently a group of 30 postmenopausal women with initially an "atypical" cervical smear 
is studied. All women underwent a short course of estrogens and after that a second cervical 
smear was made for definite diagnosis 23 women had a final diagnosis of cervical atrophy, 
and 7 patients had high-grade CIN. All smears, before as well as after the estrogen course 
were MIBI restained and the PAI was determined With the PAI-based classifier (PAI· 0.17) 
obtained from all cases of the training set and the test set of Chapter 3, all patients with 
ultimately CIN2 or CIN3 were correctly classified (PAI > 0 17) and with the exception of one 
case all women with ultimately atrophy were also correctly classified (PAI< 0.17). Application 
of the proposed diagnostic decision tree of Chapter 3 discloses that only two out of the 30 
women would have needed a repeated smear after estrogen treatment and all the other 
subjects would have been correctly referred to the regular screening program or the 
gynecologist for appropriate treatment. Further, this study demonstrated that the proliferative 
activity of high-grade CIN lesions remained unchanged during estrogen therapy, supporting 
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the elsewhere-made observations that CIN epithelium does not change under estrogen 
influence 
To investigate genetic abnormalities in CIN lesions, a reliable laboratory technique is in situ 
hybridization (ISH) with DNA probes directed at regions of chromosomes of specific interest 
This rather simple "interphase cytogenetic" procedure is the obvious method for detection of 
chromosomal abnormalities if the morphological information of the cervical lesions has to be 
preserved Thus with ISH it remains possible for the pathologist to combine information of 
genetic abnormalities of a cervical lesion with the morphological information of the same 
lesion in a parallel histological section ISH with centromere-directed DNA probes gives dot­
like signals indicative for the presence of specific chromosomes in the nuclei of the cervical 
epithelium ISH with centromere probes is especially used for chromosome counting 
(numerical) in the nuclei of interest 
The last three chapters are directed at the presence of numerical chromosomal aberrations 
simultaneously with high-risk HPV types in CIN and cervical cancer 
In Chapter 5 we analyzed 30 cases (five CINI, seven CIN2, six CIN3, six invasive 
carcinomas, and six normal samples) for the presence of numerical chromosomal 
aberrations The cases were studied by in ISH on serial 3-pm-thick paraffin tissue sections, 
using a panel of centromeric DNA probes for chromosomes 1, 3, 6, 7, 8, 11, 17, and X. For 
each chromosome, the number of ISH signals per nucleus were counted in up to 200 nuclei. 
The chromosome index (CI) is defined as the mean number of chromosome copies per 
nucleus. The CI was determined for each investigated chromosome. In normal epithelium, 
the CI was, due to nuclear truncation, reduced from 2 to 1.19. Using the mean value plus 
2.58 χ SD, a CI of > 1.4 is highly suggestive for gam of chromosomes All persisting and 
high-grade CIN lesions showed chromosome aneusomy. In most cases, when one of the 
chromosomes showed aneusomy then all investigated chromosomes showed numerical 
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changes In the CINI lesions with chromosome aneusomy, the mean CI values for all 
chromosomes did not differ significantly and had a value of 1 97 ± 0 03, indicative for 
polyploidization In CIN lesions chromosome aneusomy was focally present, while all 
invasive carcinomas exhibited diffuse chromosome aneusomy Using the CI of adjacent 
normal epithelium as a reference, it appeared that the CI ratios of chromosome 1, 7, and X 
showed a significant positive correlation with the CIN grade (r>0 74, p< 0 006) 
Chapter 6 shows the advantages of signal amplification with the catalyzed reporter 
deposition ISH (CARD-ISH) procedure above the traditional ISH method in detecting HPV 
Its in situ detection threshold of about 20 copies per cell limits routine ISH We tested the 
amplification ISH procedure on three cervical carcinoma cell lines: CaSki (500 copies of HPV 
16 DNA), HeLa (20-50 copies of HPV 18 DNA), and SiHa (one to three copies of HPV 16 
DNA) We showed that it is possible to detect one to three copies of HPV 16 DNA in situ in 
cell suspensions and as well as in routinely processed paraffin sections Secondly, the 
CARD-ISH procedure was tested on 20 cases of routinely processed cervical tissues and 
compared with the standard ISH and the polymerase chain reaction (PCR) In 95% of cases 
the results of the CARD-ISH are in accordance with PCR. 
Chapter 7 is devoted to the question whether the presence of numerical chromosomal 
aberrations for chromosome 1 is correlated with the simultaneously in situ presence with 
high-risk oncogene HPV types in CIN. For this purpose 60 cases (11 CIN1, 15 CIN2, 20 
CIN3, 9 cervical carcinomas, and 5 control subjects) were investigated by ISH and CARD-
ISH, using successively a chromosome 1 centromere probe and a DNA probe for HPV16/18 
All cervical lesions were also tested for the presence of any HPV types by PCR. Disomy (CI 
< 1.4) was detected in normal epithelium, in 36% of CINI lesions, and in 7% of CIN2 lesions 
Tetrasomy (CI > 1 4, and no cells with more than 4 ISH signals per nucleus) was found in 
64% of CIN1, 27% of CIN2 and 15% of CIN3. Hyper-tetrasomy (Cl> 1.4 and cells with more 
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than 4 copies per nucleus were present) was observed in 67% of CIN2, 85% of CIN3 and in 
all carcinomas. High-risk HPV was present in 89% of the hyper-tetrasomic cases, and the 
mean CI in HPV negative lesions was lower than in positive lesions (p=0 03). Interestingly, 
we found that the fractional area of CIN epithelium infected with HPV was sometimes equal, 
but more often greater than the fractional area with aneusomy in 77% of cases. This 
observation supports the cervical carcinogenesis model that HPV infection is necessary to 
inactivate p53 and pRb, resulting in genetic instability 
From this study the following conclusions can be drawn 1) CIN is manifested by a 
progressive dysfunction of the proliferative activity of cervical epithelial cells MIB1- positivity 
measured by an image analysis system, is a promising alternative method for the objective 
and reliable classification of CIN. 2) Measurement of MIB1-positivity measured in both biopsy 
specimens and in restamed cervical smears is a reliable procedure to differentiate cervical 
atrophy from high-grade CIN and looks to be promising for use in daily practice. 3) The 
proliferative activity index in restamed cervical smears is a constant parameter to achieve a 
reduction of diagnostic estrogen courses and subsequent Pap smears in postmenopausal 
women with cervical atrophy and "atypia" 4) It seems quite probable that cervical 
carcinomas arise from CIN lesions with focal chromosome aneusomy Chromosome 
aneusomy of chromosomes 1, 7, and X may be involved in the progression of CIN lesions. 5) 
CARD-ISH is a highly sensitive method for the routine detection of low copy number HPV 
DNA sequences below the detection limit of conventional ISH 6) Aneusomy for chromosome 
1 is highly associated with both high-grade CIN lesions and infection with high-risk HPV 
types. Infection of cervical epithelium with high-risk HPV has a broader distribution than 
chromosome aneusomy. The last observation gives support to the etiological role that HPV 
plays in cervical carcinogenesis. 
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Samenvatting 
De in dit proefschrift behandelde onderwerpen zijn. verhoogde celdeling en genetische 
afwijkingen in zowel baarmoederhalskanker als de voorstadia ervan Bij de ontstaanswijze 
hiervan is uit eerder onderzoek gebleken dat het humane papilloma virus (HPV) hierbij een 
centrale rol speelt Zo heeft moleculair onderzoek aan baarmoederhalskanker cellijnen 
aangetoond dat bepaalde HPV-typen twee regeleiwitten kunnen blokkeren die een sleutelrol 
spelen in de celcyclus pRb en p53 Daar pRb functioneert als een rem van de celcyclus en 
p53 de stabiliteit van het humane genoom bewaakt, zal inactivatie hiervan leiden tot 
respectievelijk verhoogde celdeling (hyperprohferatie) en genetische instabiliteit. 
In Hoofdstuk 1 wordt een beschrijving gegeven van het histopathologische aspect en een 
overzicht van het natuurlijk beloop van de voorstadia van baarmoederhalskanker De 
voorstadia van baarmoederhalskanker worden onderverdeeld in drie graden: cervicale 
intraepitheliale neoplasie (CIN) graad 1, 2 en 3. Deze classificatie is belangrijk omdat 
hooggradige CIN (CIN2 en CIN3) een adequate chirurgische behandeling behoeft vanwege 
de veronderstelde hoge progressieneigmg tot baarmoederhalskanker. Bij laaggradige CIN 
(CIN1), daarentegen, kan afgewacht worden omdat deze laesies geacht worden stabiel te 
blijven dan wel spontaan te verdwijnen Echter, de gradering van CIN (en andere 
goedaardige epitheliale baarmoederhalsafwijkmgen) door pathologen geschiedt op basis van 
subjectieve morfologische criteria. De observatie dat toenemende CIN gepaard gaat met 
meer tekenen van proliferatie heeft ertoe geleid om merkstoffen hiervan uitgebreid te 
bestuderen teneinde CIN en andere hierop gelijkende epitheliale baarmoederhals-
afwijkingen te kunnen classificeren op een meer objectieve wijze. 
De drie volgende hoofdstukken zijn gewijd aan proliferatie in CIN laesies en "atypische" 
epitheelatrofie bij postmenopausale vrouwen. Hoofdstuk 2 beschrijft de toepassing van het 
monoclonale antilichaam MIB1 in routinematig verwerkt weefsel van normaal en afwijkend 
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baarmoederhalsepitheel (CINI, CIN2 en CIN3). MIB1 herkent het proliferatie-geassocieerde 
Ki-67 eiwit hetwelk tijdens de celdeling in de celkern tot expressie komt Met behulp van een 
beeldverwerkingsysteem werden in het baarmoederhalsepitheel vier grootheden gemeten 
die geassocieerd zijn met proliferatie. Het bleek dat de CIN-graad sterk is gecorreleerd met 
al deze vier grootheden (0 90<r<0.97, p<0.001). Het percentage Ki-67 positieve cellen (Ki-67 
labelingsindex' Ki-67 LI) van normaal epitheel van de baarmoederhals tot CIN3 varieerde 
van 0.07 ± 0 03 tot 0 39 ± 0 06 Het negentigste percentiel van de relatieve afstand van Ki-67 
positieve kernen ten opzichte van de basaalmembraan liet de beste correlatie zien (r=0.97, 
p<0 001) 
De Hoofdstukken 3 en 4 gaan verder in op de vraag of de toepassing van MIB1 gebruikt 
kan worden om atrofisch baarmoederhalsepitheel en "atypische" atrofie te onderscheiden 
van hooggradige CIN. Deze vraag is relevant omdat in de dagelijkse praktijk 
baarmoederhalsuitstnjkjes van postmenopausale vrouwen met epitheelatrofie diagnostische 
problemen kunnen geven. Door lage oestrogeenspiegels is de uitrijping van het epitheel 
verminderd dan wel afwezig en dientengevolge kan atrofisch baarmoederhalsepitheel grote 
gelijkenis tonen met hooggradige CIN Omdat atrofisch baarmoedertialsepitheel, in 
tegenstelling tot CIN epitheel, uitrijpt tot normaal epitheel tijdens behandeling met 
oestrogenen, zal de cytopatholoog in dit geval een advies aan de gynaecoloog geven om het 
baarmoederhalsuitstnjkje na een oestrogeenkuur te herhalen. 
In Hoofdstuk 3 werd een studie uitgevoerd van 83 patiënten met de hierboven beschreven 
problematiek, onderverdeeld in een trainingset en een testset van achtereenvolgens 32 en 
51 gevallen. Van de trainingset werden zowel MIB1 gekleurde weefselcoupes als hieraan 
voorafgaande MIB1 herkleurde baarmoederhalsuitstrijkjes bestudeerd. Gebruikmakende van 
het eerder genoemde beeldverwerkingsysteem werd de MIB1-positiviteit bepaald in 
weefselcoupes van biopten. Voor de MIB1 herkleurde baarmoederhalsuitstrijkjes werd een 
puntmeting methode ontwikkeld om de proliferatie activiteit index (PAI) te bepalen. Normaal 
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en atrofisch baarmoederhalsepitheel toonden een significant lagere proliferatie dan CIN2 en 
CIN3, in zowel biopten (respectievelijk LI. 0 07 ± 0 01 en 0 02 + 0.01 vs 0.25 ± 0 05 en 0 41 
± 0 05, p<0.001) als in de uitstnjkjes (respectievelijk PAI 0.01 ± 0.02 en 0 04 ± 0 02 vs. 0.34 
± 0.07 en 0 59 ± 0 07, p<0.001). Toepassing van de uit de trainingset verkregen, op de PAI 
gebaseerde classificatieparameter op de gevallen uit de testset toonde aan dat alle gevallen 
correct werden geclassificeerd als atrofie (n=25) of hooggradige CIN (n=26). Op basis 
hiervan werd voor postmenopausale vrouwen een op de PAI gebaseerde diagnostische 
beslisboom ontworpen. Indien PAI < 0.10 is, wordt de vrouw terugverwezen naar het 
reguliere bevolkingsonderzoek-programma omdat de waarschijnlijkheid dat ze hooggradige 
CIN heeft < 0.1% is en als PAI > 0 25 is zal ze verwezen worden naar de gynaecoloog omdat 
het waarschijnlijk is dat hooggradige CIN aanwezig is > 99 9% bedraagt Alleen MIB1 
herkleurde baarmoederhalsuitstrijkjes met PAI waarden tussen deze drempels dienen na 
een oestrogenen kuur te worden herhaald De toepassing van zulk een beslisboom zal 
resulteren in een reductie van oestrogeen kuren bij tenminste 90% van de postmenopausale 
vrouwen 
In Hoofdstuk 4 werd een groep van 30 postmenopausale vrouwen bestudeerd die 
aanvankelijk een "atypisch" baarmoederhalsuitstrijkje hadden en vervolgens een kuur met 
oestrogenen kregen en een tweede uitstnjkje voor een definitieve diagnose. Van deze 
vrouwen bleken 23 uiteindelijk atrofie te hebben en 7 hooggradige CIN De uitstnjkjes van 
zowel voor als na de kuur werden MIB1 herkleurd en de PAI bepaald. Met de op de PAI 
gebaseerde classificatieparameter uit de training- en de testsets, beschreven in Hoofdstuk 3 
(PAI' 0 17), werden alle patiënten met uiteindelijk CIN2 of CIN3 correct geclassificeerd (PAI 
> 0.17) en met uitzondering van één casus werden ook alle vrouwen met uiteindelijk atrofie 
goed geclassificeerd (PAI < 0.17). Toepassing van de beslisboom uit Hoofdstuk 3 liet zien 
dat slechts twee van de dertig vrouwen een herhaald vervolguitstnjkje nodig zouden hebben 
na een hormoonkuur De rest van de vrouwen zou al direct na het eerste uitstrijkje correct 
naar de gynaecoloog verwezen zijn voor adequate behandeling, dan wel naar het reguliere 
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bevolkingsonderzoek. Verder toonde deze studie aan dat de proliferatie activiteit van 
hooggradige CIN laesies met veranderde na de oestrogeen kuur hetgeen de hypothese 
steunt dat CIN epitheel niet gevoelig is voor oestrogenen 
Om genetische afwijkingen in CIN laesies te kunnen vaststellen is in situ hybridisatie (ISH) 
met gelabelde DNA snuffelmoleculen die binden aan specifieke gebieden op een bepaald 
chromosoom een goede laboratoriumtechniek Met name wanneer de morfologische 
informatie van meestal kleine baarmoederhalsafwijkmgen behouden moet blijven is ISH de 
aangewezen methode In tegenstelling tot andere moleculaire technieken, kan de patholoog 
met ISH de genetische informatie van een baarmoederhalsafwijking tegelijkertijd koppelen 
aan het morfologische beeld in een parallel coupe. ISH die gebruikt maakt van 
snuffelmoleculen die gericht zijn tegen de centromeerregio's van de verschillende 
chromosomen geeft puntvormige signalen die duiden op de aanwezigheid van specifieke 
chromosomen in de kernen. ISH gericht op centromeerregio's wordt speciaal gebruikt voor 
het tellen van het aantal chromosomen (numeriek) in die kernen waarin men geïnteresseerd 
is. 
De laatste drie hoofdstukken zijn gericht op de aanwezigheid van numerieke 
chromosoomafwijkingen in combinatie met HPV typen die een verhoogd risico geven op 
progressieve CIN en baarmoederhalskanker In Hoofdstuk 5 hebben we 30 gevallen (vijf 
CIN1, zeven CIN2, zes CIN3, zes gevallen van baarmoederhalskanker en zes normalen) 
onderzocht op de aanwezigheid van numerieke chromosoomafwijkingen De gevallen 
werden onderzocht met ISH op 3 micron dikke seriecoupes gebruikmakende van 
centromeer-snuffelmoleculen voor de chromosomen 1, 3, 6, 7, 8, 11, 17 en X. Voor elk 
chromosoom werd van in totaal 200 kernen het aantal ISH signalen per kern geteld. De 
chromosoom index (Cl) is het gemiddeld aantal chromosoomkopieen per kern en werd voor 
elk chromosoom afzonderlijk bepaald. Normaal baarmoederhalsepitheel zal een Cl hebben 
van 2, echter in histologische coupes hebben we te maken met aangesneden kernen en zal 
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de Cl dus altijd kleiner zijn dan twee In onze opzet van de studie bleek normaal 
baarmoederhalsepitheel een Cl te hebben van 119. Gebruikmakende van het gemiddelde 
van Cl plus 2.58 χ de standaarddeviatie, is een Cl > 1 4 sterk suggestief voor toename van 
het aantal van de desbetreffende chromosomen (2 signalen per kern is "disomie" en > 2 
signalen per kern is "aneusomie") Alle persisterende en hooggradige CIN afwijkingen 
toonden chromosoom aneusomie voor alle onderzochte chromosomen In CIN1 laesies 
verschilde de gemiddelde Cl met significant voor de onderlinge chromosomen en had een 
waarde van 1.97 + 0 03, hetwelk duidt op polyploidisatie (meervoud van diploidie). In bijna 
alle CIN laesies was de chromosoom aneusomie plaatselijk aanwezig, terwijl de gevallen van 
baarmoederhalskanker diffuus chromosoom aneusomie toonden Gebruik makende van de 
Cl van aangrenzend normaal epitheel als referentiewaarde, toonden de Cl ratio's van 
chromosomen 1, 7 en X een positieve correlatie met de CIN graad (r > 0 74, ρ < 0 006) 
Hoofdstuk 6 laat de voordelen zien van signaalversterkmg met de CARD-ISH techniek 
boven de traditionele ISH methode voor het detecteren van HPV De conventionele ISH kan 
maximaal 20 HPV kopieën per kern aantonen. De CARD-ISH procedure werd getest op drie 
kankercellijnen We lieten zien dat het mogelijk was om m de SiHa cellijn één tot drie kopieën 
van HPV 16 DNA aan te tonen m zowel celsuspensies als routinematig verwerkt paraffine 
materiaal Vervolgens werd de CARD-ISH procedure getest op 20 routinematig verwerkte 
baarmoederhalsweefsels voor de aanwezigheid van HPV en werden de resultaten 
vergeleken met de standaard ISH methode en met de polymerase ketting reactie (PCR) In 
95% van de gevallen waren de resultaten van de CARD-ISH in overeenstemming met de 
PCR. 
Hoofdstuk 7 is gewijd aan de vraag of de aanwezigheid van numerieke 
chromosoomafwijkingen voor chromosoom 1 in plaats en tijd is gecorreleerd met de 
aanwezigheid van oncogene HPV typen (HPV typen met een verhoogd risico op CIN en 
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baarmoederhalskanker) in de weefselcoupes van CIN laesies en baarmoederhalskanker 
Voor dit doel werden 60 gevallen (11 CINI, 15 CIN2, 20 CIN3, 9 gevallen van 
baarmoederhalskanker en 5 normale gevallen) onderzocht met ISH en CARD-ISH, 
gebruikmakende van achtereenvolgens een chromosoom 1 centromeer-snuffelmolecuul en 
een DNA snuffelmolecuul voor HPV16/18 Tevens werden alle gevallen met behulp van PCR 
getest op de aanwezigheid van alle bekende HPV typen met PCR Disomie (Cl< 1.4) werd 
aangetoond in normaal epitheel, in 36% van CIN1 en in 7% van CIN2 laesies Tetrasomie 
(Cl > 1 4, en geen cellen met meer dan 4 ISH signalen per kern) werd gevonden m 64% van 
CIN1, in 27% van CIN2 en in 15% van CIN3 laesies Hyper-tetrasomie (Cl> 1 4 en cellen 
met meer dan 4 kopieën per kern) werd gezien in 67% van CIN2, in 85% van CIN3 en in alle 
gevallen van baarmoederhalskanker. Oncogene HPV typen waren aanwezig in 89% van de 
hyper-tetrasome gevallen en de gemiddelde Cl in HPV negatieve laesies was lager dan in 
positieve laesies (p=0.03) Het viel op dat de epitheelaantastmg door HPV vaak uitgebreider 
was dan de aneusome epitheelgebieden (77%). Deze bevinding ondersteunt de 
aanwijzingen dat bij het ontstaan van baarmoederhalskanker HPV infectie vooraf lijkt te gaan 
aan genetische instabiliteit 
Uit de resultaten van dit onderzoek kunnen de volgende conclusies worden getrokken· 1) 
CIN uit zich als een progressieve dysfunctie van de proliferatie activiteit van epitheliale cellen 
van de baarmoederhals 2) Het meten van MIB1-positiviteit in zowel histologische coupes 
van de baarmoederhals als in herkleurde baarmoederhalsuitstrijkjes is een betrouwbare 
methode om te differentieren tussen atrofie en hooggradige CIN en lijkt veelbelovend voor 
toepassing in de dagelijkse praktijk 3) De aldus gemeten proliferatie activiteit m MIB1 
herkleurde baarmoederhalsuitstrijkjes is een goede parameter voor de cytopathologische 
diagnostiek. Op basis hiervan wordt een daling van het aantal oestrogeen kuren en van 
daarop volgende uitstnjkjes in postmenopausale vrouwen met cervicale atrofie en "atypie" 
bereikt 4) Het is aannemelijk dat baarmoederhalskanker ontstaat vanuit CIN laesies met 
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plaatselijk chromosoom aneusomie Met name aneusomie voor de chromosomen 1, 7 en X 
lijken betrokken te zijn bij de progressie van CIN laesies 5) CARD-ISH is een zeer gevoelige 
methode voor het aantonen van lage kopie aantallen van HPV DNA. 6) Aneusomie voor 
chromosoom 1 is sterk geassocieerd met zowel hooggradige CIN laesies als infectie met 
oncogene HPV typen. Infectie van epitheel van de baarmoederhals met oncogene HPV 
typen lijkt vooraf te gaan aan chromosoom aneusomie. De laatste observatie strookt met de 
belangrijke rol die HPV speelt als oorzakelijke factor bij baarmoederhalskanker. 
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STELLINGEN 
behorende bij het proefschrift 
Hyperprohferation and genetic instability 
in cervical lesions 
J. Bulten 
Nijmegen, 8 november 2000 
1 
Laag- en hoog-gradige dysplastische cervix afwijkingen kunnen goed en reproduceerbaar 
van elkaar worden onderscheiden met behulp van MIB1 
(Dit proefschrift) 
2 
MIBI-herkleunng van Papanicolaou gekleurde cervix uitstnjkjes met atypische atrofie 
voorkomt hormoonkuren, herhalmgsuitstnjkjes en veel onrust bij patiënten 
(Dit proefschrift) 
3 
Infectie van cervix epitheel met het oncogene humane papilloma virus gaat vooraf aan 
aneusomie 
(Dit proefschrift) 
4 
Integratie van het humane papilloma virus lijkt noodzakelijk te zijn voor neoplastische 
veranderingen van cervix epitheel en kan middels m situ hybridisatie onderzoek opgespoord 
worden 
(Dit proefschrift) 
5 
Ten behoeve van een goede interpretatie van de kleurresultaten in de histopathologie dient 
de opleiding tot patholoog een uitgebreide cursus te omvatten over de theoretische 
achtergronden van weefselfixatie, inbedtechnieken, het snijden van coupes, alle 
voorkomende histotechmsche kleuringen en natuurlijk ook de bediening van het mikroskoop 
(Bancroft JD, Stevens A Theory and Practice of Histological Techniques 4th ed Churchill 
Livingstone 1996, New York) 
6 
Pathologen zijn geneigd zich meer te laten leiden door panels met een beperkt aantal 
markers dan door de morfologie, zich onvoldoende realiserend dat de morfologie van cellen 
en weefsels wordt bepaald door ontelbare eiwitten 
7 
Het is onverstandig het succes van het medisch cumculum alléén te baseren op de evaluatie 
ervan door medisch studenten 
8 
Tentoongestelde kunst in ziekenhuizen heeft een groot gehalte aan cultuurpessimisme en 
zou, ter bescherming van de patient, alléén geëxposeerd moeten worden in operatiekamers 
9 
Het toekennen van een eredoctoraat in de theologie aan Ton Koopman is ook een postume 
hulde aan Johann Sebastian Bach 
10 
Het toestaan van expenmenten op menselijke embryo's geeft overtollige IVF-embryo's een 
nieuwe toekomst, nieuwe kansen en een lokkende, medische glansrol in een "brave new 
world" 
11 
Het populaire bouwen van huizen in de dertigerjaren stijl leidt tot geschiedvervalsing 
12 
Het feit dat Johann Sebastian Bach muziek voor wereldlijke gebeurtenissen opnieuw 
gebruikte voor kerkelijke aangelegenheden (en andersomi) maakt dat ook voor hem geldt er 
is geen koe zo zwart of er zit wel een vlekje aan" 
13 
Wandelen verdient als een van de weinige sporten een ecologisch keurmerk 


